392 pending office actions • 268 clients • 326 examiners • 152 art units • 0 of 392 (0%) have an AI response strategy ready • 433 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 389 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 389 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 13 (3%) |
| §103 only | 244 (62%) |
| §102 only | 19 (5%) |
| §112 only | 20 (5%) |
| Double-patenting only | 2 (1%) |
| Double-patenting + other | 3 (1%) |
| No statute on record | 91 (23%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MISIASZEK, AMBER ALTSCHUL | 3 | 47.0% | +24.6% |
| HOPPE, EMMA RUTH | 3 | 42.9% | +49.2% |
| LEE, WILLIAM Y | 3 | 47.8% | +34.1% |
| DIAMOND, ALAN D | 3 | 71.2% | +8.2% |
| MARI VALCARCEL, FERNANDO MARIANO | 3 | 49.0% | +20.3% |
| CUNNINGCHEN, KATHLEEN MARY | 3 | 63.8% | +59.5% |
| SHOWALTER, ALEXANDER KEITH | 3 | 52.1% | +53.0% |
| HUANG, GIGI GEORGIANA | 3 | 31.8% | +30.4% |
| LUNDE, GRACE HENRY | 3 | 63.6% | +37.5% |
| CANELLA, KAREN A | 3 | 62.6% | +32.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17875719 | WEARABLE DEVICE AND METHOD FOR REMOTE OPTICAL MONITORING OF INTRAOCULAR PRESSURE | TOTH, KAREN E | 183d overdue |
| 17843896 | THYMIDINE KINASE GENE | KELLY, ROBERT M | 161d overdue |
| 17378404 | NEURAL NETWORK ARCHITECTURES FOR LINKING BIOLOGICAL SEQUENCE VARIANTS BASED ON MOLECULAR PHENOTYPE, AND SYSTEMS AND METHODS THEREFOR | BICKHAM, DAWN MARIE | 141d overdue |
| 17963651 | SYSTEMS AND METHODS FOR ACCESS MANAGEMENT AND CLUSTERING OF GENOMIC, PHENOTYPE, AND DIAGNOSTIC DATA | MISIASZEK, AMBER ALTSCHUL | 111d overdue |
| 17068135 | SYSTEMS AND METHODS FOR COMPLEX BIOMOLECULE SAMPLING AND BIOMARKER DISCOVERY | KRIANGCHAIVECH, KETTIP | 73d overdue |
| 17196825 | METHOD AND SYSTEM FOR ESTIMATING PHYSICAL QUANTITIES OF A PLURALITY OF MODELS USING A SAMPLING DEVICE | FIGUEROA, KEVIN W | 72d overdue |
| 18526879 | METHODS, SYSTEMS, AND MEDIA FOR DETERMINING A HORMONE LEVEL AND A HORMONAL STATE OF A SUBJECT | REYES, REGINALD R | 53d overdue |
| 18481891 | SKIN PERFUSION MONITORING DEVICE | NATNITHITHADHA, NAVIN | 43d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18254433 | METHODS FOR CLASSIFICATION OF LIVER DISEASE | HOPPE, EMMA RUTH | 146d overdue |
| 17616281 | COMPOSITIONS AND METHODS RELATING TO TUMOR ACTIVATED T CELL ENGAGERS | LUNDE, GRACE HENRY | 127d overdue |
| 16718092 | NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF | CANELLA, KAREN A | 118d overdue |
| 17963651 | SYSTEMS AND METHODS FOR ACCESS MANAGEMENT AND CLUSTERING OF GENOMIC, PHENOTYPE, AND DIAGNOSTIC DATA | MISIASZEK, AMBER ALTSCHUL | 111d overdue |
| 16889530 | SYSTEMS AND METHODS FOR QUERYING DATABASES USING INTERACTIVE SEARCH PATHS | MARI VALCARCEL, FERNANDO MARIANO | 110d overdue |
| 17998527 | MULTISPECIFIC ANTIBODIES TARGETING CD38 AND BCMA AND USES THEREOF | CUNNINGCHEN, KATHLEEN MARY | 100d overdue |
| 16785411 | OPHTHALMIC COMPOSITION | SHOWALTER, ALEXANDER KEITH | 97d overdue |
| 16908426 | OPHTHALMIC COMPOSITION | SHOWALTER, ALEXANDER KEITH | 93d overdue |
| Art Unit | Apps |
|---|---|
| 3791 | 13 |
| 1627 | 12 |
| 1626 | 11 |
| 1683 | 10 |
| 3783 | 9 |
| 1682 | 9 |
| 1636 | 8 |
| 3684 | 7 |
| 1798 | 6 |
| 1638 | 6 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19357014 | A SYSTEM AND METHOD FOR ULTRASOUND-ENHANCED DELIVERY OF DRUGS | Sonikure Holdings Limited | FARRAR, LAUREN PENG | 3783 | §103 | Final Rejection | 54d | Pending | Oct 13, 2025 |
| 19347574 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS | BEXSON BIOMEDICAL, INC. | SHIAO, YIH-HORNG | 1691 | §102 | Non-Final OA | 5d | Pending | Oct 01, 2025 |
| 19330712 | SENSOR-BASED MACHINE LEARNING IN A HEALTH PREDICTION ENVIRONMENT | Evidation Health, Inc. | MISIASZEK, AMBER ALTSCHUL | 3682 | §103 | Non-Final OA | 71d | Pending | Sep 16, 2025 |
| 19303223 | PERSONALIZED WELLNESS SYSTEMS AND METHODS OF USE | Onikoroshi, LLC | KRIANGCHAIVECH, KETTIP | 1686 | Other | Non-Final OA | 30d overdue | Pending | Aug 18, 2025 |
| 19303233 | PERSONALIZED WELLNESS SYSTEMS AND METHODS OF USE | Onikoroshi, LLC | WHALEY, PABLO S | 3619 | §103 | Final Rejection | 22d | Pending | Aug 18, 2025 |
| 19292383 | SENSORY GAMMA STIMULATION THERAPY IMPROVES SLEEP QUALITY AND MAINTAINS FUNCTIONAL ABILITY IN ALZHEIMERS DISEASE PATIENTS | Cognito Therapeutics, Inc. | MATTHEWS, CHRISTINE HOPKINS | 3791 | §103 | Final Rejection | 46d | Pending | Aug 06, 2025 |
| 19292344 | METHODS AND SYSTEMS FOR NEURAL STIMULATION VIA VISUAL, AUDITORY AND PERIPHERAL NERVE STIMULATIONS | Cognito Therapeutics, Inc. | MALAMUD, DEBORAH LESLIE | 3792 | §103 | Non-Final OA | 20d | Pending | Aug 06, 2025 |
| 19236732 | METHODS, COMPOSITONS AND SYSTEMS FOR ANALYTE DETECTION | Stellaromics, Inc. | SISSON, BRADLEY L | 1682 | §103 | Final Rejection | 40d | Pending | Jun 12, 2025 |
| 19232280 | DOUBLE BLIND WINE TASTING | Cliink LLC | EL-HAGE HASSAN, ABDALLAH A | 3623 | §103 | Final Rejection | 97d overdue | Pending | Jun 09, 2025 |
| 19210753 | METHODS FOR TREATING PROSTATE CANCER WITH RADIOPHARMACEUTICALS | Artbio, Inc. | PERREIRA, MELISSA JEAN | 1618 | §103 | Final Rejection | 2d overdue | Pending | May 16, 2025 |
| 19205483 | SYSTEMS AND METHODS FOR ENDOSCOPE LOCALIZATION | Noah Medical Corporation | FRITH, SEAN A | 3798 | §103 | Non-Final OA | 28d | Pending | May 12, 2025 |
| 19187780 | METHODS AND SYSTEMS FOR VERIFYING ANTI-TAMPERING OF DATA | Fin3 Technologies, Inc. | ZHANG, DUAN | 3699 | §103 | Non-Final OA | 3d overdue | Pending | Apr 23, 2025 |
| 19183502 | Fully Automatic Instrument System for Biochemical Assays | Alamar Biosciences, Inc. | THOMPSON, CURTIS A | 1798 | §103 | Final Rejection | 1d overdue | Pending | Apr 18, 2025 |
| 19181117 | METHODS AND SYSTEMS FOR INTER-MODULE TRANSPORT IN TRAPPED ION QUANTUM COMPUTERS | Universal Quantum Ltd | COLE, BRANDON S | 2128 | §103 | Final Rejection | 29d overdue | Pending | Apr 16, 2025 |
| 19056045 | COMPOSITIONS AND METHODS FOR NUCLEIC ACID MODIFICATIONS | Acrigen Biosciences | RYAN, DOUGLAS CHARLES | 1635 | Other | Final Rejection | 8d overdue | Pending | Feb 18, 2025 |
| 19056221 | METHODS FOR METHYLATION ANALYSIS OF CELL-FREE DNA | Hepta Bio, Inc. | HOPPE, EMMA RUTH | 1683 | §103 | Final Rejection | 84d overdue | Pending | Feb 18, 2025 |
| 19054472 | SYSTEMS AND METHODS FOR WASTEWATER HEAT RECOVERY | Epic Cleantec Inc. | ARANT, HARRY E | 3763 | §103 | Final Rejection | 82d | Pending | Feb 14, 2025 |
| 19053053 | SYSTEMS AND METHODS FOR NUTRIGENOMICS AND NUTRIGENETIC ANALYSIS | Cipher Genetics, Inc. | VANNI, GEORGE STEVEN | 1686 | Other | Final Rejection | 17d overdue | Pending | Feb 13, 2025 |
| 19025976 | METHODS OF USE FOR AZA-QUINAZOLINE COMPOUNDS | Iambic Therapeutics, Inc. | FETTEROLF, BRANDON J | 1626 | Other | Non-Final OA | 43d overdue | Pending | Jan 16, 2025 |
| 19025546 | SYSTEMS AND METHODS FOR DETERMINING DATABASE PERMISSIONS | Datawalk Spólka Akcyjna | SKHOUN, HICHAM | 2164 | §103 | Non-Final OA | 52d overdue | Pending | Jan 16, 2025 |
| 19012569 | PLANT BASED HONEY COMPOSITION | Melibio, Inc. | TRAN, LIEN THUY | 1793 | Other | Non-Final OA | 71d overdue | Pending | Jan 07, 2025 |
| 19005188 | FOLDABLE CONNECTING STRUCTURE FOR BED FRAME | Zinus Inc. | ADEBOYEJO, IFEOLU A | 3679 | §103 | Non-Final OA | 18d overdue | Pending | Dec 30, 2024 |
| 18990538 | BED DEVICE SYSTEM AND METHODS | Eight Sleep Inc. | ALAM, MIRZA F | 2688 | §103 | Non-Final OA | 21d | Pending | Dec 20, 2024 |
| 18973571 | SURFACE STRUCTURE FOR FLUID MANIPULATION | Volta Labs, Inc. | FLETCHER III, WILLIAM P | 1759 | §103 | Non-Final OA | 26d overdue | Pending | Dec 09, 2024 |
| 18958126 | METHODS FOR MAXIMUM JOINT PROBABILITY ASSIGNMENT TO SEQUENTIAL BINARY RANDOM VARIABLES IN QUADRATIC TIME COMPLEXITY | January, Inc. | BLANCHETTE, JOSHUA B | 3684 | §103 | Non-Final OA | 35d overdue | Pending | Nov 25, 2024 |
| 18935201 | METHODS AND DEVICES FOR MEMBRANE CHARACTERIZATION WITH ULTRASOUND AND OPTICAL ILLUMINATION | Otonexus Medical Technologies, Inc. | IP, JASON M | 3797 | §103 | Final Rejection | 46d | Pending | Nov 01, 2024 |
| 18922750 | APPARATUS AND METHOD FOR CHARACTERIZATION OF ACUTE OTITIS MEDIA | Otonexus Medical Technologies, Inc. | BRUTUS, JOEL F | 3797 | §103 | Non-Final OA | 35d overdue | Pending | Oct 22, 2024 |
| 18923491 | SYSTEMS AND METHODS FOR A DATA-DRIVEN WORKFLOW PLATFORM | Elementum Ltd. | LI, MENG | 2437 | §112 | Non-Final OA | 82d | Pending | Oct 22, 2024 |
| 18904684 | SENSOR-BASED MACHINE LEARNING IN A HEALTH PREDICTION ENVIRONMENT | Evidation Health, Inc. | MISIASZEK, AMBER ALTSCHUL | 3682 | §103 | Non-Final OA | 23d overdue | Pending | Oct 02, 2024 |
| 18903693 | SYSTEMS AND METHODS FOR ANOMALY DETECTION USING EXPLAINABLE MACHINE LEARNING ALGORITHMS | Hawk AI GmbH | MAGUIRE, LINDSAY M | 3619 | §101 | Final Rejection | 9d | Pending | Oct 01, 2024 |
| 18890594 | COMPOSITIONS AND METHODS FOR THERAPEUTIC DELIVERY | Genvivo, Inc. | JOHNSON, ALLISON MARIE | 1638 | Other | Non-Final OA | 84d overdue | Pending | Sep 19, 2024 |
| 18883711 | ARTIFICIAL INTELLIGENCE PHYSICS-BASED MODELING OF CARDIAC PARAMETERS | Delbeat, Inc. | HAKALA, ALAN GREGORY | 2617 | §103 | Non-Final OA | 14d | Pending | Sep 12, 2024 |
| 18824159 | METHODS AND SYSTEMS FOR CHROMATOGRAPHIC DETERMINATION OF A METABOLOME | Park City Venture Partners, LLC | SANGHERA, STEVEN G.S. | 3684 | §103 | Non-Final OA | 51d overdue | Pending | Sep 04, 2024 |
| 18820806 | FOLDABLE ARTICLES OF FURNITURE AND METHODS OF ASSEMBLING FOLDABLE ARTICLES OF FURNITURE | Zinus Inc. | WRIGHT, KIMBERLEY S | 3637 | §102 | Non-Final OA | 42d overdue | Pending | Aug 30, 2024 |
| 18818407 | SURVEILLANCE SYSTEM AND METHODS FOR AUTOMATED WAREHOUSES | Nomagic sp z o.o. | ORTIZ ROMAN, DENISSE Y | 3627 | §103 | Non-Final OA | 26d overdue | Pending | Aug 28, 2024 |
| 18812671 | MICRONEEDLE DEVICES, AND USES THEREOF | Mindera Corporation | MYERS, CARLA J | 1682 | §103 | Final Rejection | 7d | Pending | Aug 22, 2024 |
| 18806109 | Unsupervised Machine Learning Methods | Ampel Biosolutions, LLC | DAUNER, JOSEPH G | 1682 | §103 | Final Rejection | 28d | Pending | Aug 15, 2024 |
| 18800872 | INTEGRATED FINANCIAL SERVICES PLATFORMS AND METHODS OF USE | Figure Technologies, Inc. | EKECHUKWU, CHINEDU U | 3695 | §103 | Final Rejection | 12d | Pending | Aug 12, 2024 |
| 18796204 | METHODS OF PROCESSING A BIOFLUID SAMPLE | PrognomiQ, Inc. | NGUYEN, NAM P | 1678 | Other | Final Rejection | 127d overdue | Pending | Aug 06, 2024 |
| 18789446 | COLLEGE ADMISSIONS AND CAREER MENTORSHIP PLATFORM | Empowerly, Inc. | CHAWAN, VIJAY B | 2658 | Other | Non-Final OA | 21d | Pending | Jul 30, 2024 |
| 18784718 | OPHTHALMIC COMPOSITION | Sydnexis, Inc. | LEE, WILLIAM Y | 1623 | Other | Non-Final OA | 10d overdue | Pending | Jul 25, 2024 |
| 18767864 | TEREPHTHALIC ACID ESTERS FORMATION | 9449710 Canada Inc. | CUTLIFF, YATE KAI RENE | 1692 | Other | Non-Final OA | 46d | Pending | Jul 09, 2024 |
| 18767896 | APPARATUS AND METHOD FOR SPEECH PROCESSING USING A DENSELY CONNECTED HYBRID NEURAL NETWORK | Reflex Technologies, Inc. | ARMSTRONG, ANGELA A | 2659 | §103 | Non-Final OA | 126d overdue | Pending | Jul 09, 2024 |
| 18766429 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PRESBYOPIA | Lenz Therapeutics Operations, Inc. | DIAMOND, ALAN D | 3991 | Other | Non-Final OA | 5d overdue | Pending | Jul 08, 2024 |
| 18765156 | CONTACT LENS COMPOSITIONS AND METHODS FOR THE TREATMENT OF PRESBYOPIA | Lenz Therapeutics Operations, Inc. | DIAMOND, ALAN D | 3991 | Other | Non-Final OA | 5d overdue | Pending | Jul 05, 2024 |
| 18765066 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PRESBYOPIA | Lenz Therapeutics Operations, Inc. | DIAMOND, ALAN D | 3991 | §112 | Non-Final OA | 5d overdue | Pending | Jul 05, 2024 |
| 18763980 | PARTICLES AND METHODS OF ASSAYING | Seer, Inc. | FRITCHMAN, REBECCA M | 1758 | Other | Non-Final OA | 88d overdue | Pending | Jul 03, 2024 |
| 18762386 | RELAXATION-BASED MAGNETIC RESONANCE THERMOMETRY WITH A LOW-FIELD SINGLE-SIDED MRI SCANNER | Promaxo, Inc. | JASANI, ASHISH SHIRISH | 3798 | §103 | Non-Final OA | 63d | Pending | Jul 02, 2024 |
| 18753672 | Machine Learning Disease Prediction and Treatment Prioritization | Ampel Biosolutions, LLC | STRIEGEL, THEODORE CHARLES | 1685 | Other | Non-Final OA | 138d overdue | Pending | Jun 25, 2024 |
| 18753922 | Secure Electric Vehicle Charger and System Incorporating Thereof | Eve Energy Ventures Inc. | WRIGHT, BRYAN F | 2497 | §103 | Non-Final OA | 52d overdue | Pending | Jun 25, 2024 |
| 18751904 | DECENTRALIZED DATA VERIFICATION | The Assay Depot, Inc. | ANDERSON, MICHAEL D | 2433 | §103 | Non-Final OA | 31d overdue | Pending | Jun 24, 2024 |
| 18751908 | COLLAPSIBLE DENTAL SCOPE | Get-Grin Inc. | TEITELBAUM, MICHAEL E | 2422 | §103 | Non-Final OA | 46d overdue | Pending | Jun 24, 2024 |
| 18716877 | PHOSPHITE DEHYDROGENASE AS A SELECTABLE MARKER FOR MITOCHONDRIAL TRANSFORMATION | Napigen, Inc. | DEVEAU ROSEN, JASON | 1662 | §103 | Non-Final OA | 10d overdue | Pending | Jun 05, 2024 |
| 18735060 | SYSTEMS AND METHODS FOR REMOTE DENTAL MONITORING | Get-Grin Inc. | MUSSELMAN, TIMOTHY A | 3715 | Other | Final Rejection | 59d overdue | Pending | Jun 05, 2024 |
| 18734772 | COMPOSITIONS AND METHODS FOR RNA SYNTHESIS | Linearx, Inc. | REGA, KYLE THOMAS | 1636 | §112 | Non-Final OA | 9d | Pending | Jun 05, 2024 |
| 18680251 | METHODS OF PRODUCING FUNCTIONALIZED POWDER PARTICLES | Kremenak Nanotech, Inc. | YAMASAKI, ROBERT J | 1657 | §103 | Non-Final OA | 30d overdue | Pending | May 31, 2024 |
| 18678320 | SYSTEM AND METHOD FOR CORRECTING PATIENT INDEX | Cytovale Inc. | KWAK, DEAN P | 1798 | §103 | Non-Final OA | 2d overdue | Pending | May 30, 2024 |
| 18672412 | DEVICES, SYSTEMS, AND METHODS FOR TOPOGRAPHIC ANALYSIS OF A BIOLOGICAL SURFACE | Linus Biotechnology Inc. | TON, TRI T | 2877 | §103 | Final Rejection | 121d overdue | Pending | May 23, 2024 |
| 18669880 | FOLDABLE DENTAL SCOPE | Get-Grin Inc. | TEITELBAUM, MICHAEL E | 2422 | §103 | Non-Final OA | 30d | Pending | May 21, 2024 |
| 18668909 | System, Devices, and Methods for Time-Resolved Fluorescent Spectroscopy | Cedars-Sinai Medical Center | KIM, KIHO | 2884 | Other | Non-Final OA | 46d overdue | Pending | May 20, 2024 |
| 18666047 | SHELF-STABLE FORMULATIONS OF BENZOYL PEROXIDE AND METHODS OF PRODUCING SAME | BLUE HILL TECHNOLOGIES LLC | DONOHUE, SEAN R | 1618 | §103 | Final Rejection | 105d overdue | Pending | May 16, 2024 |
| 18662754 | METHODS AND SYSTEMS FOR AUDIO SAMPLE QUALITY CONTROL | Clearspeed Inc. | SHAH, ANTIM G | 2693 | §103 | Final Rejection | 38d overdue | Pending | May 13, 2024 |
| 18658055 | LOW INTENSITY FOCUSED ULTRASOUND FOR TREATING CANCER AND METASTASIS | Albert Einstein College of Medicine | LUONG, PETER | 3797 | §103 | Non-Final OA | 27d | Pending | May 08, 2024 |
| 18657531 | SYSTEMS AND METHODS FOR RESPONSIVE INSERTION AND RETRACTION OF ROBOTIC ENDOSCOPE | Noah Medical Corporation | BOICE, JAMES EDWARD | 3795 | §103 | Non-Final OA | 59d overdue | Pending | May 07, 2024 |
| 18656278 | SYSTEMS AND METHODS FOR STOOL CHARACTERIZATION AS NON-INVASIVE MEASURES OF DISEASE ACTIVITY | Cylinder Health, Inc. | RUIZ, JOSHUA DAMIAN | 3684 | §103 | Final Rejection | 30d overdue | Pending | May 06, 2024 |
| 18636423 | SYSTEMS AND METHODS FOR MULTI-CONTRAST MULTI-SCALE VISION TRANSFORMERS | Subtle Medical, Inc. | LY, TOMMY TAI | 3797 | §103 | Non-Final OA | 43d overdue | Pending | Apr 16, 2024 |
| 18634598 | ACTIVE LEARNING FOR WEARABLE HEALTH SENSOR | Evidation Health, Inc. | SZUMNY, JONATHON A | 3686 | §112 | Final Rejection | 4d overdue | Pending | Apr 12, 2024 |
| 18629321 | SUBSTITUTED BENZIMIDAZOLES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS | Epigenetix, Inc. | RAHMANI, NILOOFAR | 1691 | Other | Non-Final OA | 43d overdue | Pending | Apr 08, 2024 |
| 18628420 | COMPLEX COMPRISING A PSMA-TARGETING COMPOUND LINKED TO A LEAD OR THORIUM RADIONUCLIDE | Sciencons AS | DONOHUE, SEAN R | 1618 | Other | Final Rejection | 96d overdue | Pending | Apr 05, 2024 |
| 18627264 | LOW-AREA, LOW-POWER NEURAL RECORDING CIRCUIT, AND METHOD OF TRAINING THE SAME | Caeleste Cvba | D ABREU, MICHAEL JOSEPH | 3796 | §102 | Non-Final OA | 28d overdue | Pending | Apr 04, 2024 |
| 18615028 | MACHINE LEARNING FOR DESIGNING ANTIBODIES AND NANOBODIES IN-SILICO | Marwell Bio Inc. | MPAMUGO, CHINYERE | 3685 | §103 | Non-Final OA | 60d overdue | Pending | Mar 25, 2024 |
| 18614506 | COMPOSITIONS, METHODS AND SYSTEMS FOR PROTEIN CORONA ANALYSIS AND USES THEREOF | Seer, Inc. | RAMADAN, OMAR | 1678 | §103 | Final Rejection | 23d overdue | Pending | Mar 22, 2024 |
| 18613562 | DENSLEY-PACKED ANALYTE LAYERS AND DETECTION METHODS | Pacific Biosciences of California, Inc. | TSAI, TSUNG YIN | 2656 | §102 | Non-Final OA | 34d | Pending | Mar 22, 2024 |
| 18612795 | SYSTEMS AND METHODS FOR SAMPLE COLLECTION | Drawbridge Health, Inc. | TOMBERS, JOSEPH A | 3791 | §103 | Non-Final OA | 7d | Pending | Mar 21, 2024 |
| 18607814 | SYSTEMS AND METHODS FOR CONTRAST DOSE REDUCTION | Subtle Medical, Inc. | ALFONSO, DENISE G | 2662 | §103 | Non-Final OA | 26d overdue | Pending | Mar 18, 2024 |
| 18607804 | ULTRA-HIGH RESOLUTION CT RECONSTRUCTION USING GRADIENT GUIDANCE | Subtle Medical, Inc. | ALFONSO, DENISE G | 2662 | §103 | Non-Final OA | 26d overdue | Pending | Mar 18, 2024 |
| 18602373 | SYSTEMS AND METHODS FOR AUTOMATED SPINE SEGMENTATION AND ASSESSMENT OF DEGENERATION USING DEEP LEARNING | Subtle Medical, Inc. | YENTRAPATI, AVINASH | 2672 | §103 | Non-Final OA | 32d overdue | Pending | Mar 12, 2024 |
| 18602468 | SYSTEMS AND METHODS FOR NOISE-AWARE SELF-SUPERVISED ENHANCEMENT OF IMAGES USING DEEP LEARNING | Subtle Medical, Inc. | FUJITA, KATRINA R | 2672 | §103 | Non-Final OA | 3d overdue | Pending | Mar 12, 2024 |
| 18603041 | SYSTEMS AND METHODS FOR COMBINING DATA ANALYSES | Datawalk Spólka Akcyjna | OBISESAN, AUGUSTINE KUNLE | 2156 | §103 | Final Rejection | 12d | Pending | Mar 12, 2024 |
| 18594287 | SYSTEMS AND METHODS FOR SELF-ALIGNMENT AND ADJUSTMENT OF ROBOTIC ENDOSCOPE | Noah Medical Corporation | JOS, BASIL T | 3658 | §103 | Non-Final OA | 4d overdue | Pending | Mar 04, 2024 |
| 18594625 | A SYSTEM AND METHOD OF MERGING A CO-OPERATIVE MR-COMPATIBLE ROBOT AND A LOW-FIELD PORTABLE MRI SYSTEM | Neuro42 Inc. | ALDARRAJI, ZAINAB MOHAMMED | 3797 | §103 | Final Rejection | 23d | Pending | Mar 04, 2024 |
| 18589357 | MONITORING OF HEALTH CONDITIONS USING A REAL-TIME AND CONTINUOUS BLOOD PRESSURE MEASURING SYSTEM | Esperto Medical, Inc. | HEALY, NOAH MICHAEL | 3791 | §103 | Non-Final OA | 18d overdue | Pending | Feb 27, 2024 |
| 18585568 | SYSTEMS AND METHODS FOR MONITORING A TOOTH WHITENING REGIMEN | Get-Grin Inc. | MAHROUKA, WASSIM | 2665 | §103 | Non-Final OA | 44d overdue | Pending | Feb 23, 2024 |
| 18583701 | HIGH DYNAMIC RANGE DIGITAL QUANTITATION OF TARGETS | Enumerix, Inc. | BAILEY, STEVEN WILLIAM | 1687 | §103 | Final Rejection | 60d overdue | Pending | Feb 21, 2024 |
| 18437887 | MODULAR INTEGRATED SYSTEM MODULES | Nautilus True, LLC | FORD, GISELE D | 3633 | §103 | Non-Final OA | 86d overdue | Pending | Feb 09, 2024 |
| 18431347 | SYSTEMS AND METHODS FOR INDUCING MUSCLE CONTRACTION | Asayena, Inc. | KUO, JONATHAN T | 3792 | §103 | Non-Final OA | 60d overdue | Pending | Feb 02, 2024 |
| 18428899 | BED FRAME SUPPORT STRUCTURE, BED FRAME AND BED | Zinus Inc. | LABARGE, ALISON N | 3673 | §103 | Non-Final OA | 22d overdue | Pending | Jan 31, 2024 |
| 18425997 | SDC-2 EXOSOME COMPOSITIONS AND METHODS OF ISOLATION AND USE | Orbsen Therapeutics Limited | SPENCE, JENNIFER SUZANNE | 1633 | Other | Non-Final OA | 7d | Pending | Jan 29, 2024 |
| 18424290 | SYSTEMS AND METHODS FOR REMOTE DENTAL MONITORING | Get-Grin Inc. | BROWN JR, HOWARD D | 2488 | §103 | Non-Final OA | 43d overdue | Pending | Jan 26, 2024 |
| 18424237 | METHOD AND SYSTEM FOR PRESENTING DENTAL SCAN | Get-Grin Inc. | BHATNAGAR, ANAND P | 2668 | §102 | Non-Final OA | 19d overdue | Pending | Jan 26, 2024 |
| 18424564 | METHODS AND SYSTEMS FOR PHASE GATES IN QUANTUM COMPUTERS | Universal Quantum Ltd | STOFFA, WYATT A | 2881 | §112 | Non-Final OA | 19d overdue | Pending | Jan 26, 2024 |
| 18418855 | VECTOR FOR CANCER TREATMENT | Cancer Research Technology Limited | BATES, KEENAN ALEXANDER | 1631 | §103 | Non-Final OA | 92d overdue | Pending | Jan 22, 2024 |
| 18415394 | METHODS AND DEVICES FOR CONTINUOUS OPERATION OF A COLD-ATOM DEVICE USING A SEPARATE RESERVOIR ARRAY | Atom Computing Inc. | COOK, BRIAN S | 2187 | §103 | Final Rejection | 100d overdue | Pending | Jan 17, 2024 |
| 18411545 | METHODS AND SYSTEMS FOR AQUACULTURE | Vertical Oceans Ptd. Ltd. | MACCRATE, NICOLE PAIGE | 3642 | §103 | Final Rejection | 78d overdue | Pending | Jan 12, 2024 |
| 18410847 | PLANT BASED HAIR FIBERS | Aja Labs, Inc. | STEELE, JENNIFER A | 1789 | §103 | Non-Final OA | 52d overdue | Pending | Jan 11, 2024 |
| 18409116 | SYSTEMS AND METHODS FOR GENETICS-BASED ANALYTICS OF HEALTH, FITNESS AND SPORTS PERFORMANCE | Cipher Genetics, Inc. | HRANEK, KAREN AMANDA | 3684 | §103 | Final Rejection | 5d | Pending | Jan 10, 2024 |
| 18407758 | DISTORTION CORRECTION OF LOW FIELD MAGNETIC RESONANCE IMAGES WITH PAIRED HIGH FIELD MAGNETIC RESONANCE IMAGES USING MACHINE LEARNING | Neuro42 Inc. | KAUR, JASPREET | 2662 | §103 | Non-Final OA | 80d overdue | Pending | Jan 09, 2024 |
| 18406588 | METHODS AND SYSTEMS FOR EXPEDITED RADIOLOGICAL SCREENING | Whiterabbit.Ai Inc. | LU, ZHIYU | 2665 | §103 | Non-Final OA | 2d overdue | Pending | Jan 08, 2024 |
| 18394833 | ARTIFICIAL NANOPORES AND USES AND METHODS RELATING THERETO | Rijksuniversiteit Groningen | GERIDO, DWAN A | 1797 | §103 | Final Rejection | 14d | Pending | Dec 22, 2023 |
| 18573298 | COMPOSITIONS OF BETA-HEXOSAMINIDASE VARIANTS AND USES THEREOF | BIOMARIN PHARMACEUTICAL INC. | SWIFT, CANDICE LEE | 1657 | §103 | Non-Final OA | 4d overdue | Pending | Dec 21, 2023 |
| 18572399 | ERK1/2 AND KRAS G12C INHIBITORS COMBINATION THERAPY | Erasca, Inc. | ANDERSON, REBECCA L | 1626 | §103 | Non-Final OA | 4d overdue | Pending | Dec 20, 2023 |
| 18572412 | SHP2 AND CDK4/6 INHIBITORS COMBINATION THERAPIES FOR THE TREATMENT OF CANCER | Erasca, Inc. | KUCKLA, ANNA GRACE | 1626 | Other | Non-Final OA | 19d overdue | Pending | Dec 20, 2023 |
| 18390285 | COMPUTER-IMPLEMENTED METHOD FOR IMPROVING QUERY EXECUTION IN RELATIONAL DATABASES NORMALIZED AT LEVEL 4 AND ABOVE | Datawalk Spólka Akcyjna | MARI VALCARCEL, FERNANDO MARIANO | 2159 | §103 | Final Rejection | 74d overdue | Pending | Dec 20, 2023 |
| 18572148 | System and Method for Determining a Stool Condition | Dieta Inc. | MAHROUKA, WASSIM | 2665 | §103 | Non-Final OA | 66d overdue | Pending | Dec 19, 2023 |
| 18538944 | SEQUENTIAL ADAPTOR FOR COMBINED ULTRASOUND AND OPTOACOUSTIC DIAGNOSTIC INTERROGATION OF THE LEFT INNOMINATE VEIN | Noninvasix, Inc. | MORONESO, JONATHAN DREW | 3791 | §103 | Non-Final OA | 19d | Pending | Dec 13, 2023 |
| 18538712 | METHODS AND SYSTEMS FOR AUTOMATED GENERATION OF DIGITAL ARTIFACTS WITH ENHANCED USER EXPERIENCE | Pastbook BV | AUGUSTIN, MARCELLUS | 2682 | §103 | Non-Final OA | 97d overdue | Pending | Dec 13, 2023 |
| 18257251 | JOINT ANGLE DETERMINATION UNDER LIMITED VISIBILITY | Healthcare Outcomes Performance Company Limited | SHAH, UTPAL D | 2668 | §103 | Final Rejection | 26d overdue | Pending | Dec 08, 2023 |
| 18534083 | BALANCED SYSTEM AND METHOD FOR PRODUCTION OF MICROBIAL OUTPUT | Tenfold Technologies, LLC | CLARKE, TRENT R | 1651 | §103 | Non-Final OA | 1d overdue | Pending | Dec 08, 2023 |
| 18529530 | PLATFORMS FOR CONDUCTING VIRTUAL TRIALS | Cancer Commons | KANAAN, LIZA TONY | 3683 | §103 | Non-Final OA | 28d | Pending | Dec 05, 2023 |
| 18527596 | DETECTING SLEEPING DISORDERS | Eight Sleep Inc. | LINDSAY, BERNARD G | 2119 | §103 | Non-Final OA | 15d | Pending | Dec 04, 2023 |
| 18526879 | METHODS, SYSTEMS, AND MEDIA FOR DETERMINING A HORMONE LEVEL AND A HORMONAL STATE OF A SUBJECT | Uniq Health Ltd | REYES, REGINALD R | 3684 | §101 | Final Rejection | 53d overdue | Pending | Dec 01, 2023 |
| 18520811 | Portable Devices and Methods for Analyzing Samples | Biomeme, Inc. | MCGUIRK, JOHN SCHUYLER | 1798 | §112 | Final Rejection | 4d overdue | Pending | Nov 28, 2023 |
| 18517515 | SCALABLE NEUTRAL ATOM BASED QUANTUM COMPUTING | Atom Computing Inc. | CHANG, HANWAY | 2878 | §103 | Non-Final OA | 31d overdue | Pending | Nov 22, 2023 |
| 18562768 | BIOMARKERS FOR AGE-RELATED MACULAR DEGENERATION | BELITE BIO, LLC | RAHMANI, NILOOFAR | 1691 | §101 | Non-Final OA | 30d overdue | Pending | Nov 20, 2023 |
| 18511328 | SYSTEMS AND METHODS FOR REAL-TIME SYSTEMATIC HEALTH CARE | Tad Health Inc. | EGLOFF, PETER RICHARD | 3715 | §101 | Non-Final OA | 34d | Pending | Nov 16, 2023 |
| 18508403 | SYSTEMS AND METHODS FOR ARBITRARY LEVEL CONTRAST DOSE SIMULATION IN MRI | Subtle Medical, Inc. | SARKAR, SHIVANGI | 2666 | §103 | Non-Final OA | 49d overdue | Pending | Nov 14, 2023 |
| 18508585 | SCALABLE NEUTRAL ATOM BASED QUANTUM COMPUTING | Atom Computing Inc. | SMITH, DAVID E | 2881 | §112 | Non-Final OA | 12d | Pending | Nov 14, 2023 |
| 18502203 | SANITARY MEMBRANE LEAF PACKET AND MEMBRANE ELEMENT INCLUDING SAME | Solecta, Inc. | JEONG, YOUNGSUL | 1772 | §103 | Non-Final OA | 37d overdue | Pending | Nov 06, 2023 |
| 18558806 | POLO LIKE KINASE 4 INHIBITORS | Oric Pharmaceuticals, Inc. | HERNANDEZ, JACKSON J | 1627 | Other | Non-Final OA | 14d | Pending | Nov 03, 2023 |
| 18501724 | METHODS AND COMPOSITIONS USING AN ENGINEERED RELEASE FACTOR | Opentrons Labworks Inc. | MULDER, SCOTT EVAN | 1656 | §103 | Non-Final OA | 26d | Pending | Nov 03, 2023 |
| 18289399 | PHARMACEUTICAL COMPOSITION FOR USE IN TREATING CEREBRAL INFARCTION | Corxel Pharmaceuticals Hong Kong Limited | RAO, PADMAJA S | 1627 | Other | Non-Final OA | 12d | Pending | Nov 03, 2023 |
| 18492882 | ORAL DOSAGE FORMS OF METHYL HYDROGEN FUMARATE AND PRODRUGS THEREOF | Arbor Pharmaceuticals, LLC | BARHAM, BETHANY P | 1611 | §103 | Non-Final OA | 147d overdue | Pending | Oct 24, 2023 |
| 18486369 | LYSINE ACETYLTRANSFERASE 6A (KAT6A) INHIBITORS AND USES THEREOF | Insilico Medicine Ip Limited | ANDERSON, REBECCA L | 1626 | §102 | Non-Final OA | 43d | Pending | Oct 13, 2023 |
| 18379142 | METHODS FOR THE TREATMENT OF DIABETIC RETINOPATHY AND OTHER OPHTHALMIC DISEASES | Acucela Inc. | JAVANMARD, SAHAR | 1622 | §103 | Non-Final OA | 56d | Pending | Oct 11, 2023 |
| 18483933 | AEROSOL SAMPLE COLLECTION DEVICE | Proveris Scientific Corporation | BALAJI, KAVYA SHOBANA | 3791 | §103 | Non-Final OA | 79d overdue | Pending | Oct 10, 2023 |
| 18482789 | Functionalized Surfaces for Conversion of Carbon Dioxide | Prometheus Fuels, Inc. | WONG, EDNA | 1795 | §103 | Non-Final OA | — | Pending | Oct 06, 2023 |
| 18482776 | GAS SENSOR CALIBRATION METHOD | Vivante Health, Inc. | NIA, FATEMEH ESFANDIARI | 2855 | Other | Non-Final OA | 110d overdue | Pending | Oct 06, 2023 |
| 18285812 | GPR119 AGONISTS | Kallyope, Inc. | REILLY, SOPHIA JANE | 1627 | §112 | Non-Final OA | 30d | Pending | Oct 05, 2023 |
| 18554174 | METHODS AND SYSTEMS FOR ANALYZING COMPLEX GENOMIC REGIONS | Rprd Diagnostics, LLC | CASH, KAILEY ELIZABETH | 1683 | DP | Non-Final OA | 82d | Pending | Oct 05, 2023 |
| 18481891 | SKIN PERFUSION MONITORING DEVICE | Veriskin, Inc. | NATNITHITHADHA, NAVIN | 3791 | §101 | Non-Final OA | 43d overdue | Pending | Oct 05, 2023 |
| 18478320 | HAIR DEMINERALIZER COMPOSITION, METHODS AND USES THEREOF | K18, Inc. | WRIGHT, SARAH C | 1619 | §103 | Non-Final OA | 99d overdue | Pending | Sep 29, 2023 |
| 18477825 | SYSTEMS AND COMPOSITIONS FOR DETECTING A BIOLOGICAL SAMPLE AND METHODS THEREOF | Qcdx LLC | YU, TIAN NMN | 1681 | §103 | Non-Final OA | 114d overdue | Pending | Sep 29, 2023 |
| 18476928 | SYSTEMS AND METHODS FOR ARTIFICIAL INTELLIGENCE-ASSISTED IMAGE ANALYSIS | Sirona Medical, Inc. | BARTLEY, KENNETH | 3684 | §103 | Final Rejection | 18d overdue | Pending | Sep 28, 2023 |
| 18476600 | METHODS AND COMPOSITIONS FOR TREATING CLOSTRIDIODES DIFFICILE INFECTIONS | Matrivax, Inc. | CHO, DAVID H | 1693 | §103 | Non-Final OA | 40d | Pending | Sep 28, 2023 |
| 18470264 | COMPOSITIONS AND METHODS FOR TARGETED RNA DELIVERY | Verve Therapeutics, Inc. | ALLEY, GENEVIEVE S | 1617 | §103 | Non-Final OA | 29d overdue | Pending | Sep 19, 2023 |
| 18369788 | SYSTEMS AND METHODS FOR ENGINEERING PROTEIN ACTIVITY | Aether Biomachines, Inc. | MINCHELLA, KAITLYN L | 1685 | §103 | Final Rejection | 19d | Pending | Sep 18, 2023 |
| 18467037 | TRANS-SPLICING METHODS AND COMPOSITIONS FOR GENERATION OF SINGLE SEX OFFSPRING | Jfl Capital Management, LLC | NGUYEN, QUANG | 1631 | Other | Non-Final OA | 18d overdue | Pending | Sep 14, 2023 |
| 18466675 | MICROBIOME IDENTIFICATION AND BACTERIOPHAGE FORMULATIONS | Parallel Health, Inc. | GRIZER, CASSANDRA SENN | 1672 | §103 | Non-Final OA | 5d overdue | Pending | Sep 13, 2023 |
| 18550428 | BIOCERAMIC COMPOSITIONS FOR CANCER RECOVERY | Multiple Energy Technologies LLC | COLLINS, SEAN W | 3794 | §103 | Non-Final OA | 2d overdue | Pending | Sep 13, 2023 |
| 18464653 | SPECTROMETRY SYSTEMS, METHODS, AND APPLICATIONS | Scio Solutions Ltd. | NUR, ABDULLAHI | 2877 | §103 | Non-Final OA | 87d overdue | Pending | Sep 11, 2023 |
| 18461368 | ENGINEERED IMMUNE CELL THERAPIES | Factor Bioscience Inc. | VANHORN, ABIGAIL LOUISE | 1636 | Other | Non-Final OA | 9d overdue | Pending | Sep 05, 2023 |
| 18241733 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PRESBYOPIA | Lenz Therapeutics Operations, Inc. | WRIGHT, SARAH C | 1619 | Other | Final Rejection | 15d overdue | Pending | Sep 01, 2023 |
| 18548538 | DIRECTED LASER ENERGY TO REDUCE METAL OXIDES | Limelight Steel Inc. | SMOOT, MORIAH SIMONE MCMIL | 1733 | §103 | Non-Final OA | 21d | Pending | Aug 31, 2023 |
| 18547794 | RIBONUCLEOTIDE REDUCTASE (RNR) INHIBITORS AND USES THEREOF | Boundless Bio, Inc. | DAHLIN, HEATHER RAQUEL | 1629 | §103 | Non-Final OA | 93d overdue | Pending | Aug 24, 2023 |
| 18455209 | METHODS AND COMPOSITIONS FOR SYNTHETIC BIOMARKERS | Earli Inc. | REGA, KYLE THOMAS | 1636 | §103 | Non-Final OA | 66d overdue | Pending | Aug 24, 2023 |
| 18453798 | COMPOUNDS AND METHODS FOR MODULATING HER2 | Iambic Therapeutics, Inc. | PATEL, SAGAR S | 1626 | Other | Non-Final OA | 17d overdue | Pending | Aug 22, 2023 |
| 17914004 | RESPIRATOR FACE MASKS FOR PROTECTION FROM AIRBORNE PARTICLES | Encellin, Inc. | EZELUOMBA, MIRIAM NCHEKWUBECHU | 1776 | §103 | Non-Final OA | 16d overdue | Pending | Aug 18, 2023 |
| 18234826 | 2-S RIMANTADINE AND 2-R RIMANTADINE FOR TREATING CANCER | Toragen, Inc. | YOO, SUN JAE | 1621 | §103 | Non-Final OA | 28d | Pending | Aug 16, 2023 |
| 18450638 | COMBINATION OF RAF INHIBITOR AND MEK INHIBITOR | Day One Biopharmaceuticals, Inc. | HUI, SAN MING R | 1627 | Other | Non-Final OA | 11d overdue | Pending | Aug 16, 2023 |
| 18451003 | POLYPEPTIDES INCLUDING A BETA-TRICALCIUM PHOSPHATE-BINDING SEQUENCE AND USES THEREOF | Theradaptive, Inc. | KATAKAM, SUDHAKAR | 1658 | §103 | Non-Final OA | 31d overdue | Pending | Aug 16, 2023 |
| 18546560 | TRPM8 AGONISTS AS COOLING AGENTS AND FOR THE TREATMENT OF DISEASE | Concentric Analgesics, Inc. | NOLAN, JASON MICHAEL | 1623 | §102 | Non-Final OA | 8d | Pending | Aug 15, 2023 |
| 18546260 | SYSTEMS AND METHODS FOR CELL ANALYSIS | Deepcell, Inc. | SETH, MANAV | 2672 | §103 | Non-Final OA | 42d overdue | Pending | Aug 11, 2023 |
| 17759944 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | Design Therapeutics, Inc. | HAVLIN, ROBERT H | 1626 | §102 | Non-Final OA | 71d | Pending | Aug 10, 2023 |
| 18446625 | SYSTEMS AND METHODS FOR HARDWARE DEVICE FINGERPRINTING | Callsign, Inc. | POUDEL, SAMIKSHYA NMN | 2436 | §103 | Final Rejection | 10d overdue | Pending | Aug 09, 2023 |
| 18446731 | METHOD AND DEVICE FOR REMOTE OPTICAL MONITORING OF INTRAOCULAR PRESSURE | Smartlens, Inc. | PHAM, KATHERINE-PH MINH | 3781 | §103 | Non-Final OA | 35d overdue | Pending | Aug 09, 2023 |
| 18276588 | ANTIBACTERIAL COMPOUNDS | Blacksmith Medicines, Inc. | JACKSON, SHAWQUIA | 1626 | — | Non-Final OA | 31d overdue | Pending | Aug 09, 2023 |
| 18365899 | METHODS AND SYSTEMS FOR GENERATING PERSONALIZED TREATMENTS VIA CAUSAL INFERENCE | Evidation Health, Inc. | LULTSCHIK, WILLIAM G | 3682 | §103 | Non-Final OA | 49d overdue | Pending | Aug 04, 2023 |
| 18362622 | RETRACTABLE NEEDLE CATHETER DELIVERY APPARATUS | Skydance Vascular, Inc. | ALLEN, ROBERT F | 3783 | Other | Non-Final OA | 19d overdue | Pending | Jul 31, 2023 |
| 18361001 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | Neupharma, Inc. | WHITE, DAWANNA SHAR-DAY | 1627 | §112 | Non-Final OA | 82d | Pending | Jul 28, 2023 |
| 18360022 | PLANT-BASED MEAT REPLICAS WITH BINDERS FOR PLANT-BASED FOOD PRODUCTS | Epogee, LLC | MORENO, LARK JULIA | 1793 | §103 | Non-Final OA | 131d overdue | Pending | Jul 27, 2023 |
| 18357976 | METHODS OF CELL THERAPIES | The Trustees of Columbia University in the City of New York | SMITH, ADAM MICHAEL | 1638 | Other | Non-Final OA | 78d overdue | Pending | Jul 24, 2023 |
| 18357320 | AZA-QUINAZOLINE COMPOUNDS AND METHODS OF USE | Iambic Therapeutics, Inc. | FETTEROLF, BRANDON J | 1626 | Other | Non-Final OA | 114d overdue | Pending | Jul 24, 2023 |
| 18225052 | FRUIT AND/OR VEGETABLE BASED COMPOSITIONS AND METHODS OF PREPARING THE SAME | The Well Fruit Company, Inc. | SMITH, CHAIM A | 1791 | §103 | Non-Final OA | 53d overdue | Pending | Jul 21, 2023 |
| 18356949 | ENHANCEMENT OF ADOPTIVE CELL TRANSFER | Cellvie Inc. | WESTON, ALYSSA G | 1633 | §102 | Non-Final OA | 16d overdue | Pending | Jul 21, 2023 |
| 18356688 | PLATELET ALPHA-GRANULES FOR DELIVERY OF MULTIPLE PROTEINS | Csts Health Care Inc. | BOWLES, DAVID PAUL | 1654 | §103 | Non-Final OA | 30d | Pending | Jul 21, 2023 |
| 18354506 | SYSTEMS AND METHODS FOR REAL-TIME SEARCH BASED GENERATIVE ARTIFICIAL INTELLIGENCE | SuSea, Inc. | RAMIREZ BRAVO, BEATRIZ A | 2146 | §103 | Final Rejection | 73d overdue | Pending | Jul 18, 2023 |
| 18351305 | COMPOSITIONS AND METHODS FOR SOFT TISSUE AUGMENTATION18348273 | Athena Devices, Inc. | MEYERS, ELIZABETH ANNE | 1617 | DPOther | Non-Final OA | 79d | Pending | Jul 12, 2023 |
| 18220789 | METHODS AND SYSTEMS FOR DIAGNOSING DISEASES | Newomics Inc. | MUI, CHRISTINE T | 1797 | §103 | Non-Final OA | 53d overdue | Pending | Jul 11, 2023 |
| 17909162 | HETEROCYCLE CONTAINING STAT INHIBITORS AND COMPOSITIONS | Centessa Pharmaceuticals (Uk) Limited | ROMERO, KRISTEN WANG | 1624 | §112 | Non-Final OA | 113d overdue | Pending | Jul 06, 2023 |
| 18347479 | CRYSTALLINE FORMS OF A TYK2 INHIBITOR | Ventyx Biosciences, Inc. | DEKARSKE, MADELINE MCGUIRE | 1622 | Other | Non-Final OA | 46d | Pending | Jul 05, 2023 |
| 18344616 | METHODS FOR CLASSIFICATION OF LIVER DISEASE | Tensor Biosciences, Inc. | HOPPE, EMMA RUTH | 1683 | §103 | Non-Final OA | 60d overdue | Pending | Jun 29, 2023 |
| 18340562 | DEVICES AND METHODS FOR SAMPLE COLLECTION | Predicine, Inc. | SINES, BRIAN J | 1796 | §102 | Non-Final OA | 58d overdue | Pending | Jun 23, 2023 |
| 18340765 | ORAL DELIVERY OF THERAPEUTIC MAMMALIAN CELLS | Vitabolus Inc. | MCCORMICK, CATHERINE LYNN | 1638 | Other | Non-Final OA | 54d | Pending | Jun 23, 2023 |
| 18339927 | DETOX HAIR AND SCALP CLEANSER COMPOSITION, METHODS AND USES THEREOF | K18, Inc. | MATTISON, LORI K | 1619 | §103 | Non-Final OA | 78d overdue | Pending | Jun 22, 2023 |
| 18258714 | SYSTEMS AND METHODS FOR PRESERVATION OF A CERVICOVAGINAL FLUID SAMPLE | NextGen Jane, Inc. | MCCORMACK, ERIN KATHLEEN | 3791 | §103 | Non-Final OA | 10d overdue | Pending | Jun 21, 2023 |
| 18212477 | LONG-LIVED INSULIN DELIVERY CANNULA | Pacific Diabetes Technologies Inc. | STIMPERT, PHILIP EARL | 3783 | §103 | Non-Final OA | 5d overdue | Pending | Jun 21, 2023 |
| 18336201 | SYSTEMS AND METHODS FOR IDENTIFYING AND DISTINGUISHING GENETIC SAMPLES | Revere Biosensors, LLC | CROW, ROBERT THOMAS | 1683 | Other | Non-Final OA | 14d | Pending | Jun 16, 2023 |
| 18334975 | MEDICAL CART FOR MAGNETIC TREATMENT OF MIDDLE EAR CONDITIONS | Otomagnetics, Inc. | REDDY, SUNITA | 3791 | §112 | Non-Final OA | 5d overdue | Pending | Jun 14, 2023 |
| 18266970 | OLIGONUCLEOTIDE ANALOGUE THERAPEUTICS FOR TREATMENT OF NEUROMUSCULAR DISEASE | Neubase Therapeutics, Inc. | HASTINGS, ALISON AZAR | 1627 | Other | Non-Final OA | 4d overdue | Pending | Jun 13, 2023 |
| 18209171 | METHODS AND SYSTEMS FOR LIDAR AND LIDAR CONTROL | Hesai Technology Co., Ltd. | HELLNER, MARK | 3645 | §103 | Non-Final OA | 9d | Pending | Jun 13, 2023 |
| 18332906 | ORAL LIQUID SUSPENSION OF PAN-RAF KINASE INHIBITOR | Day One Biopharmaceuticals, Inc. | MOU, LIYUAN | 1628 | §103 | Non-Final OA | 31d overdue | Pending | Jun 12, 2023 |
| 18332403 | SPLIT-FRAME CARDIAC VALVES | Open Stent Solution SAS | MATHEW, SEEMA | 3774 | §103 | Non-Final OA | 32d overdue | Pending | Jun 09, 2023 |
| 18256276 | HALF-LIFE EXTENDING COMPOSITIONS AND METHODS | Janux Therapeutics, Inc. | SAOUD, CHRISTINE J | 1645 | Other | Non-Final OA | 37d overdue | Pending | Jun 07, 2023 |
| 18330847 | SEQUENCING BY EMERGENCE | Xgenomes Corp. | LU, FRANK WEI MIN | 1683 | §103 | Final Rejection | 10d overdue | Pending | Jun 07, 2023 |
| 18256278 | PEPTIDE COMPOSITIONS AND METHODS FOR ANTI-CD3 BINDING DOMAINS | Janux Therapeutics, Inc. | YAO, LEI | 1642 | Other | Non-Final OA | 9d | Pending | Jun 07, 2023 |
| 18256091 | COMBINATION THERAPIES FOR THE TREATMENT OF CANCER | Erasca, Inc. | BURKETT, DANIEL JOHN | 1624 | Other | Non-Final OA | 131d overdue | Pending | Jun 06, 2023 |
| 18328685 | MICROFLUIDIC DETERMINATION OF HETEROGENEOUS OBJECTS | Amberstone Biosciences, Inc. | WALLENHORST, MAUREEN | 1797 | §103 | Non-Final OA | 78d overdue | Pending | Jun 02, 2023 |
| 18328429 | SYSTEMS AND METHODS FOR PROCESSING STOOL SAMPLES | Biomesense, Inc. | NGUYEN, HENRY H | 1758 | §103 | Non-Final OA | 19d | Pending | Jun 02, 2023 |
| 18328598 | NUCLEIC ACID PRODUCTS AND METHODS OF ADMINISTRATION THEREOF | Factor Bioscience Inc. | ZHU, JIANJIAN | 1631 | §103 | Non-Final OA | 22d | Pending | Jun 02, 2023 |
| 18327740 | METHOD OF TREATING SCHIZOPHRENIA OR SCHIZOPHRENIFORM DISORDER | Curemark, LLC | BROWE, DAVID | 1617 | §103 | Non-Final OA | 62d | Pending | Jun 01, 2023 |
| 18202423 | SYSTEMS AND METHODS FOR DETECTING GENETIC ALTERATIONS | Predicine, Inc. | SISSON, BRADLEY L | 1682 | Other | Non-Final OA | 50d overdue | Pending | May 26, 2023 |
| 18323674 | LASOFOXIFENE COMBINATION TREATMENT OF ER+ BREAST CANCER THAT HAS PROGRESSED ON A CDK4/6 INHIBITOR | Eli Lilly And Company | NOTTINGHAM, KYLE GREGORY | 1621 | §103 | Non-Final OA | 22d overdue | Pending | May 25, 2023 |
| 18254433 | METHODS FOR CLASSIFICATION OF LIVER DISEASE | Tensor Biosciences, Inc. | HOPPE, EMMA RUTH | 1683 | Other | Non-Final OA | 146d overdue | Pending | May 25, 2023 |
| 18038542 | MODULAR TEXTILE RECYCLING SYSTEM AND PROCESS | Ravel Holdings, Inc. | ROSEBACH, CHRISTINA H.W. | 1766 | §103 | Non-Final OA | 49d overdue | Pending | May 24, 2023 |
| 18200121 | BIOREACTOR SYSTEMS AND METHODS FOR CULTURING CELLS | TurtleTree Labs Pte. Ltd. | BRAZIN, JACQUELINE | 1798 | §103 | Non-Final OA | 27d | Pending | May 22, 2023 |
| 18199440 | METHOD, DRIVE CIRCUIT, AND LIDAR FOR LASER EMISSION CONTROL | Hesai Technology Co., Ltd. | BAGHDASARYAN, HOVHANNES | 3645 | §103 | Non-Final OA | 30d overdue | Pending | May 19, 2023 |
| 18319195 | SYSTEMS AND METHODS FOR OPTIMIZING BUSINESS WORKFLOWS | Flowpatterns | SINGLETARY, TYRONE E | 3625 | §103 | Final Rejection | 111d overdue | Pending | May 17, 2023 |
| 18195761 | Bag System Containing a Nutrient Composition Comprising Whole Food Sole Source Meal | Kate Farms, Inc. | JUSTICE, GINA CHIEUN YU | 1617 | Other | Non-Final OA | 45d overdue | Pending | May 10, 2023 |
| 18314077 | COMPOSITIONS AND METHODS RELATED TO TUMOR ACTIVATED ANTIBODIES TARGETING PSMA AND EFFECTOR CELL ANTIGENS | Janux Therapeutics, Inc. | CUNNINGCHEN, KATHLEEN MARY | 1646 | Other | Non-Final OA | 38d overdue | Pending | May 08, 2023 |
| 18313146 | METHODS FOR DETECTION OF NUCLEOTIDE MODIFICATION | BLUECAT IP LIMITED | GIAMMONA, FRANCESCA FILIPPA | 1681 | Other | Non-Final OA | 30d overdue | Pending | May 05, 2023 |
| 18035478 | RAF INHIBITOR FOR TREATING LOW GRADE GLIOMA | DANA-FARBER CANCER INSTITUTE, INC. | HERNANDEZ, JACKSON J | 1627 | Other | Final Rejection | 29d overdue | Pending | May 04, 2023 |
| 18251817 | SPECIFIC SUBSTRATES AND PRODUCTS OF HSD17B13 AS MARKERS OF LIVER DISEASE AND BIOMARKERS FOR LIVER DISEASE TREATMENT | Inipharm, Inc. | MISHRA, DEEPA | 1657 | §103 | Non-Final OA | 81d overdue | Pending | May 04, 2023 |
| 18311108 | SYSTEMS AND METHODS FOR ENHANCED IMMUNOTHERAPIES | Hangzhou Qihan Biotech Co., Ltd. | CUNNINGCHEN, KATHLEEN MARY | 1646 | §103 | Non-Final OA | 66d overdue | Pending | May 02, 2023 |
| 18250829 | POLYPEPTIDES HAVING ANTI-INFLAMMATORY EFFECTS AND USES THEREOF | União Brasileira De Educação Católica, Brasília | KATAKAM, SUDHAKAR | 1658 | §112 | Non-Final OA | 53d | Pending | Apr 27, 2023 |
| 18033470 | METHODS FOR PROCESSING FETAL SUPPORT TISSUE | BIOTISSUE HOLDINGS INC. | PAULUS, ERIN VIRGINIA | 1631 | §103 | Non-Final OA | 27d | Pending | Apr 24, 2023 |
| 18305234 | PORTABLE ATMOSPHERIC WATER GENERATOR | Spout Ventures Inc. | KURTZ, BENJAMIN M | 1779 | §103 | Non-Final OA | 21d | Pending | Apr 21, 2023 |
| 18033280 | SHUTTLE AGENT PEPTIDES OF MINIMAL LENGTH AND VARIANTS THEREOF ADAPTED FOR TRANSDUCTION OF CAS9-RNP AND OTHER NUCLEOPROTEIN CARGOS | Feldan Bio Inc. | LIPPOLIS, ALEXANDRA ROSE | 1637 | §102 | Non-Final OA | 20d | Pending | Apr 21, 2023 |
| 18249879 | ANTIBODIES TARGETING HER2 AND CD3 AND USES THEREOF | Janux Therapeutics, Inc. | FAUST, AMBER KATHLEEN | 1643 | DPOther | Final Rejection | 61d | Pending | Apr 20, 2023 |
| 18249886 | MULTISPECIFIC ANTIBODIES FOR TARGETING CD28 AND PD-L1 AND METHODS OF USE THEREOF | Janux Therapeutics, Inc. | TAYLOR, LIA ELAN | 1641 | §103 | Non-Final OA | 33d | Pending | Apr 20, 2023 |
| 18303467 | SYSTEM FOR ACCELERATING DISSOLUTION OF MAFIC AND ULTRAMAFIC MATERIALS | Project Vesta, Pbc | HOBBS, MICHAEL L | 1799 | §103 | Non-Final OA | 103d overdue | Pending | Apr 19, 2023 |
| 18032527 | COMPOSITIONS AND METHODS FOR T-CELL RECEPTOR IDENTIFICATION | Rootpath Genomics, Inc. | GODDARD, LAURA B | 1642 | §103 | Non-Final OA | 98d overdue | Pending | Apr 18, 2023 |
| 18135668 | COMPOSITIONS AND METHODS FOR PRODUCING BICARBONATE AND MINERALS | Andes AG, Inc. | ARMATO JR, DENNIS IGNATIUS | 1651 | §103 | Non-Final OA | 35d overdue | Pending | Apr 17, 2023 |
| 18135484 | VIRAL AND HOST BIOMARKERS FOR DETECTION, THERAPEUTIC EFFECTIVENESS, AND MONITORING OF CANCER LINKED TO SARS-CoV-2 AND HUMAN PAPILLOMA VIRUS | Lifegene-Biomarks, Inc. | PENNINGTON, HALLIE NICOLE | 1671 | §103 | Non-Final OA | 60d overdue | Pending | Apr 17, 2023 |
| 18032329 | PEPTIDE-BASED TRANSDUCTION OF NON-ANIONIC POLYNUCLEOTIDE ANALOGS FOR GENE EXPRESSION MODULATION | Feldan Bio Inc. | VANHORN, ABIGAIL LOUISE | 1636 | Other | Non-Final OA | 7d | Pending | Apr 17, 2023 |
| 18301361 | METHODS FOR THE TREATMENT OF PRESBYOPIA | Lenz Therapeutics Operations, Inc. | WILSON, JERICA KATLYNN | 1621 | §103 | Non-Final OA | 49d overdue | Pending | Apr 17, 2023 |
| 18134854 | COMPOSITIONS AND METHODS FOR THE PREVENTION OF TYPE I HYPERSENSITIVITY REACTIONS | Iggenix, Inc. | TRAN HO, LAM THUY VI | 1647 | §103 | Non-Final OA | 25d overdue | Pending | Apr 14, 2023 |
| 18249168 | INHALED FORMULATIONS OF PGDH INHIBITORS AND METHODS OF USE THEREOF | Myoforte Therapeutics, Inc. | WHITE, DAWANNA SHAR-DAY | 1627 | Other | Non-Final OA | 18d overdue | Pending | Apr 14, 2023 |
| 18031724 | ANTIBODIES TARGETING PSMA AND CD3 AND USES THEREOF | Janux Therapeutics, Inc. | JUEDES, AMY E | 1644 | §112 | Final Rejection | 27d | Pending | Apr 13, 2023 |
| 18133380 | METHODS AND SYSTEMS FOR HUMAN-IN-THE-LOOP VEHICULAR COMMAND AND CONTROL USING IMMERSIVE SYNTHETIC VISION | Rotor Technologies, Inc. | VELASQUEZ VANEGAS, RAFAEL | 3667 | §103 | Final Rejection | 24d overdue | Pending | Apr 11, 2023 |
| 18297328 | MEDICAL INSTRUMENT AND MEDICAL METHOD FOR LOCALIZED DRUG DELIVERY | Mercator Medsystems, Inc. | BOSWORTH, KAMI A | 3783 | §103 | Non-Final OA | 91d overdue | Pending | Apr 07, 2023 |
| 18296982 | METHODS AND APPARATUSES FOR DETECTING RESPIRATORY INFECTIONS | Controlpoint Inc. | KOLKER, DANIEL E | 1645 | §103 | Non-Final OA | 30d overdue | Pending | Apr 06, 2023 |
| 18192212 | SYSTEMS AND METHODS FOR TRACKING EMISSIONS | Nzero, Inc. | RUSS, COREY V | 3629 | §103 | Non-Final OA | 29d overdue | Pending | Mar 29, 2023 |
| 18028992 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ANGIOPOIETIN LIKE 7 (ANGPTL7) RELATED DISEASES | Empirico Inc. | WHITEMAN, BRIAN A | 1636 | Other | Non-Final OA | 30d | Pending | Mar 28, 2023 |
| 18028651 | PHARMACEUTICAL COMPOSITIONS OF AMORPHOUS SOLID DISPERSIONS AND METHODS OF PREPARATION THEREOF | Shenzhen Pharmacin Co., Ltd. | HEITMEIER, KENDALL NICOLE | 1621 | Other | Non-Final OA | 15d | Pending | Mar 27, 2023 |
| 18125474 | COMPOSITIONS AND METHODS FOR REDUCING GREENHOUSE GAS | Rumin8 Pty Ltd. | LEE, WILLIAM Y | 1623 | Other | Final Rejection | 8d | Pending | Mar 23, 2023 |
| 18188315 | COMPOSITIONS AND METHODS FOR GENETIC MODIFICATION AND TARGETING | Qihan-Egenesis Hong Kong Limited | WILSON, MICHAEL C | 1638 | §103 | Non-Final OA | 133d overdue | Pending | Mar 22, 2023 |
| 18245978 | Amorphous Form of Isoquinoline Derivative | Vtv Therapeutics LLC | CHEN, PO-CHIH | 1621 | §102 | Non-Final OA | 79d overdue | Pending | Mar 20, 2023 |
| 18186146 | BIOPSY SYSTEM FOR ENHANCED TISSUE HARVESTING | Data Driven Diagnostic Sciences, Inc., Dba D3Sciences | DOUGHERTY, SEAN PATRICK | 3791 | §103 | Non-Final OA | 62d | Pending | Mar 17, 2023 |
| 18185662 | SYSTEMS AND METHODS FOR NUCLEAR FUSION | Aquarius Energy, Inc. | GARNER, LILY CRABTREE | 3646 | §102 | Non-Final OA | 50d | Pending | Mar 17, 2023 |
| 18122187 | DYNAMIC IN-TRANSIT STRUCTURING OF UNSTRUCTURED MEDICAL DOCUMENTS | Xcures, Inc. | ZECHER, CORDELIA P K | 2100 | §103 | Non-Final OA | 19d overdue | Pending | Mar 16, 2023 |
| 18179986 | DISSOLVABLE MATRICES | Thorne HealthTech, Inc. | ARMSTRONG, SUSANNAH SIPPLE | 1616 | §103 | Non-Final OA | 128d overdue | Pending | Mar 07, 2023 |
| 18116566 | SYSTEMS AND METHODS FOR QUERYING DATA | Mondoo, Inc. | MARI VALCARCEL, FERNANDO MARIANO | 2159 | §103 | Final Rejection | 53d | Pending | Mar 02, 2023 |
| 18024159 | STAT INIHIBITORY COMPOUNDS AND COMPOSITIONS | Centessa Pharmaceuticals (Uk) Limited | SHOWALTER, ALEXANDER KEITH | 1629 | Other | Non-Final OA | 72d overdue | Pending | Mar 01, 2023 |
| 18024236 | MEDIUM- OR MACRO-CYCLIC BENZYL-SUBSTITUTED HETEROCYCLE DERIVATIVES AND THEIR USES AS OREXIN-2 RECEPTOR AGONISTS | Centessa Pharmaceuticals (Uk) Limited | WILLIS, DOUGLAS M | 1624 | §112 | Non-Final OA | 37d overdue | Pending | Mar 01, 2023 |
| 18115342 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF CANCERS | Xlink Therapeutics, Inc. | ORWIG, KEVIN S | 3991 | §103 | Non-Final OA | 223d overdue | Pending | Feb 28, 2023 |
| 18043142 | COMBINATION THERAPY OF A RAF INHIBITOR AND A MEK INHIBITOR FOR THE TREATMENT OF SARCOMA | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | PURDY, KYLE A | 1611 | §103 | Final Rejection | 31d overdue | Pending | Feb 27, 2023 |
| 18114469 | ORAL PHARMACEUTICAL COMPOSITION COMPRISING ZONISAMIDE AND PROCESS OF PREPARATION THEREOF | Azurity Pharmaceuticals, Inc. | HUANG, GIGI GEORGIANA | 1613 | Other | Non-Final OA | 10d overdue | Pending | Feb 27, 2023 |
| 18114410 | ORAL PHARMACEUTICAL COMPOSITION COMPRISING ZONISAMIDE AND PROCESS OF PREPARATION THEREOF | Azurity Pharmaceuticals, Inc. | HUANG, GIGI GEORGIANA | 1613 | Other | Final Rejection | — | Pending | Feb 27, 2023 |
| 18113399 | ACTIVATABLE IL-18 POLYPEPTIDES | Bright Peak Therapeutics AG | CHATTIN, AMY MARIE | 1643 | §103 | Final Rejection | 5d overdue | Pending | Feb 23, 2023 |
| 18113409 | MODIFIED IL-18 POLYPEPTIDES | Bright Peak Therapeutics AG | GURLEY, JAMI MICHELLE | 1647 | Other | Final Rejection | 22d | Pending | Feb 23, 2023 |
| 18172928 | ANTIBODY MOLECULES THAT BIND TO NKP30 AND USES THEREOF | Marengo Therapeutics, Inc. | SUNSHINE, HANNAH LOUISE | 1647 | Other | Non-Final OA | 22d overdue | Pending | Feb 22, 2023 |
| 18112665 | METHODS AND APPARATUSES FOR DETECTING BIOMOLECULES | Randall Davis | MUI, CHRISTINE T | 1797 | §103 | Final Rejection | 56d | Pending | Feb 22, 2023 |
| 18171909 | ANTIMITOTIC TETRAPEPTIDE-ANTIBODY CONJUGATES AND METHODS OF USING SAME | Angiex, Inc. | LUNDE, GRACE HENRY | 1641 | Other | Non-Final OA | 43d overdue | Pending | Feb 21, 2023 |
| 18164392 | MODULAR PRE-LOADED MEDICAL IMPLANTS AND DELIVERY SYSTEMS | Cardiac Dimensions Pty. Ltd. | MANNAN, MIKAIL A | 3774 | §103 | Final Rejection | 21d | Pending | Feb 03, 2023 |
| 18007356 | DENDRITIC CELL ACTIVATING THERAPY AS AN ADJUNCT TO RADIATION THERAPY | Montefiore Medical Center | BASET, NESHAT | 3798 | §103 | Non-Final OA | 17d overdue | Pending | Jan 30, 2023 |
| 18007369 | USES OF GLUCOCORTICOID RECEPTOR (GR) ANTAGONIST AND ANDROGEN RECEPTOR (AR) DEGRADER COMBINATIONS | Oric Pharmaceuticals, Inc. | ISMAIL, REHANA | 1625 | §103 | Non-Final OA | 9d overdue | Pending | Jan 30, 2023 |
| 18102268 | EXTENDED RELEASE 5-HT RECEPTOR AGONISTS FOR NEUROLOGICAL CONDITIONS | Diamond Therapeutics Inc. | SZNAIDMAN, MARCOS L | 1628 | §103 | Non-Final OA | 8d | Pending | Jan 27, 2023 |
| 18018519 | ADAPTER POLYPEPTIDES AND METHODS OF USING THE SAME | Spot Biosystems Ltd. | BOESEN, AGNIESZKA | 1672 | §103 | Non-Final OA | 34d | Pending | Jan 27, 2023 |
| 18102296 | ADMINISTRATION OF MODULATORS OF 5-HT AND / OR AMPA RECEPTORS FOR TREATING NEUROLOGICAL CONDITIONS | The Royal Institution for the Advancement of Learning/McGill University | HUI, SAN MING R | 1627 | §103 | Final Rejection | 21d | Pending | Jan 27, 2023 |
| 18157599 | COMPOSITION AND METHOD FOR TREATING EYE DISEASES | Frontera Therapeutics, Inc. | PAULUS, ERIN VIRGINIA | 1631 | §103 | Non-Final OA | 11d overdue | Pending | Jan 20, 2023 |
| 18157224 | MTORC1 MODULATORS AND USES THEREOF | Aeovian Pharmaceuticals, Inc. | HIRAKIS, SOPHIA P | 1623 | Other | Non-Final OA | 49d overdue | Pending | Jan 20, 2023 |
| 18157280 | SYSTEMS AND METHODS FOR MODELING DENTAL STRUCTURES | Get-Grin Inc. | LUCCHESI, NICHOLAS D | 3772 | §103 | Final Rejection | 66d overdue | Pending | Jan 20, 2023 |
| 18150988 | CELL PRESERVATION REAGENTS AND METHODS OF USE | Truckee Applied Genomics, LLC | ORWIG, KEVIN S | 3991 | Other | Non-Final OA | 189d overdue | Pending | Jan 06, 2023 |
| 18148991 | SYSTEMS AND METHODS FOR PREDICTING, DETECTING, AND MONITORING OF ACUTE ILLNESS | Evidation Health, Inc. | EVANS, ASHLEY ELIZABETH | 3687 | §103 | Non-Final OA | 16d overdue | Pending | Dec 30, 2022 |
| 18148227 | PROCESS FOR MANUFACTURING AN ELECTRICALLY CONDUCTING DEVICE FROM LIGNOCELLULOSIC MATERIAL | SAS Woodoo | SHEWAREGED, BETELHEM | 1785 | §103 | Non-Final OA | 11d overdue | Pending | Dec 29, 2022 |
| 18003835 | COMPOSITIONS FOR GENOME EDITING AND METHODS OF USE THEREOF | Cibus Biotechnologies, Inc. | TAKENAKA, RISA | 1632 | §112 | Non-Final OA | 27d | Pending | Dec 29, 2022 |
| 18069585 | RECOMBINANT MODIFIED FIBROBLAST GROWTH FACTORS AND THERAPEUTIC USES THEREOF | Trefoil Therapeutics, Inc. | DEBERRY, REGINA M | 1647 | §103 | Final Rejection | 33d | Pending | Dec 21, 2022 |
| 18069858 | MEDICAL FLUID INJECTION APPARATUS AND METHOD WITH REUSABLE PATCH | Enable Injections, Inc. | RADOMSKI, MARTIN ADAM | 3783 | §103 | Non-Final OA | 8d | Pending | Dec 21, 2022 |
| 18002036 | THYROMIMETICS | Autobahn Therapeutics, Inc. | IVANOVA, SVETLANA M | 1627 | §103 | Non-Final OA | 16d overdue | Pending | Dec 15, 2022 |
| 18078649 | CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONISTS | Spruce Biosciences, Inc. | RONEY, CELESTE A | 1612 | Other | Non-Final OA | 99d overdue | Pending | Dec 09, 2022 |
| 18001427 | METHODS FOR TREATING OR PREVENTING CHRONIC KIDNEY DISEASE | Arthrosi Therapeutics, Inc. | OTTON, ALICIA L | 1699 | §103 | Final Rejection | 46d overdue | Pending | Dec 09, 2022 |
| 18064181 | CELLULAR GLYCOSAMINOGLYCAN COMPOSITIONS AND METHODS OF MAKING AND USING | Tega Therapeutics, Inc. | FRONDA, CHRISTIAN L | 1652 | Other | Non-Final OA | 45d overdue | Pending | Dec 09, 2022 |
| 18009612 | SYSTEMS AND DEVICES FOR CONTROLLED DRUG DELIVERY | BEXSON BIOMEDICAL, INC. | PONTON, JAMES D | 3783 | §103 | Non-Final OA | 35d | Pending | Dec 09, 2022 |
| 18001064 | INHIBITORS OF NEK7 KINASE | Halia Therapeutics, Inc. | BELL, SARA ELIZABETH | 1625 | Other | Final Rejection | 34d | Pending | Dec 07, 2022 |
| 18061333 | METHODS AND SYSTEMS FOR DROPLET MANIPULATION | Volta Labs, Inc. | PARISI, JESSICA DANIELLE | 1684 | §103 | Non-Final OA | 91d overdue | Pending | Dec 02, 2022 |
| 18073663 | COMPOSITIONS AND METHODS FOR TREATING AND SUPPRESSING ALLERGIC RESPONSES | Iggenix, Inc. | YOUTCHOM PENDIE, EMMANUEL LED | 1647 | §103 | Non-Final OA | 98d overdue | Pending | Dec 02, 2022 |
| 18059370 | METHODS OF CAPTURING CELL-FREE METHYLATED DNA AND USES OF SAME | Sinai Health System | LU, FRANK WEI MIN | 1683 | DP | Non-Final OA | — | Pending | Nov 28, 2022 |
| 18054824 | SYSTEMS AND METHODS FOR HYBRID IMAGING AND NAVIGATION | Noah Medical Corporation | SURGAN, ALEXANDRA L | 3799 | §102 | Final Rejection | 131d overdue | Pending | Nov 11, 2022 |
| 18054810 | SYSTEMS AND METHODS FOR ROBOTIC ENDOSCOPIC SUBMUCOSAL DISSECTION | Noah Medical Corporation | BOICE, JAMES EDWARD | 3795 | §103 | Non-Final OA | 87d overdue | Pending | Nov 11, 2022 |
| 17998527 | MULTISPECIFIC ANTIBODIES TARGETING CD38 AND BCMA AND USES THEREOF | Virtuoso Binco, Inc. | CUNNINGCHEN, KATHLEEN MARY | 1646 | Other | Non-Final OA | 100d overdue | Pending | Nov 11, 2022 |
| 18054784 | METHODS AND SYSTEMS FOR DISPOSABLE ENDOSCOPE | Noah Medical Corporation | GHIMIRE, SHANKAR RAJ | 3795 | §103 | Non-Final OA | 6d | Pending | Nov 11, 2022 |
| 18054676 | CELL-FREE DNA SIZE DETECTION | Accuragen Holdings Limited | SCHLOOP, ALLISON ELIZABETH | 1683 | §103 | Non-Final OA | 9d | Pending | Nov 11, 2022 |
| 17998391 | THERAPEUTIC COMBINATIONS COMPRISING A CRAF INHIBITOR | Novartis AG | MCKOY, QUINCY ANDRE | 1626 | §103 | Final Rejection | 93d overdue | Pending | Nov 10, 2022 |
| 18053332 | SUBSTITUTED PYRIDAZINONES FOR USE IN THE TREATMENT OF NEUROMUSCULAR DISEASES | Edgewise Therapeutics, Inc. | CHICKS, ASHLI ARIANA | 1626 | Other | Non-Final OA | 4d overdue | Pending | Nov 07, 2022 |
| 18053326 | PYRIDAZINONE COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISEASES | Edgewise Therapeutics, Inc. | ROBINSON, MIKHAIL O'DONNEL | 1627 | Other | Non-Final OA | 34d | Pending | Nov 07, 2022 |
| 18049757 | SARS-COV-2 INHIBITORS HAVING COVALENT MODIFICATIONS FOR TREATING CORONAVIRUS INFECTIONS | Insilico Medicine Ip Limited | HAVLIN, ROBERT H | 1626 | Other | Final Rejection | 142d overdue | Pending | Oct 26, 2022 |
| 17969052 | METHODS AND SYSTEMS FOR REMOTE CONTROLLED VEHICLE | Rotor Technologies, Inc. | REDA, MATTHEW J | 3665 | §103 | Non-Final OA | 27d | Pending | Oct 19, 2022 |
| 17964399 | MORTAL PLURIPOTENT STEM CELLS | Accelerated Biosciences Corp. | NOBLE, MARCIA STEPHENS | 1632 | §101 | Non-Final OA | 28d | Pending | Oct 12, 2022 |
| 17963651 | SYSTEMS AND METHODS FOR ACCESS MANAGEMENT AND CLUSTERING OF GENOMIC, PHENOTYPE, AND DIAGNOSTIC DATA | Ix Layer Inc. | MISIASZEK, AMBER ALTSCHUL | 3682 | §101 | Final Rejection | 111d overdue | Pending | Oct 11, 2022 |
| 17963362 | DETECTION CIRCUIT FOR ADJUSTING WIDTH OF OUTPUT PULSES, RECEIVING UNIT, LASER RADAR | Hesai Technology Co., Ltd. | HODGES, SUSAN E | 2425 | §103 | Final Rejection | 19d | Pending | Oct 11, 2022 |
| 17918069 | CHEMICALLY MODIFIED GUIDE RNAS FOR GENOME EDITING WITH CAS9 | Verve Therapeutics, Inc. | BABIC, CHRISTOPHER M | 1633 | §103 | Non-Final OA | 9d overdue | Pending | Oct 10, 2022 |
| 17938488 | SMALL SAMPLE ACCESSORIES FOR OPTICAL SPECTROMETERS | Scio Solutions Ltd. | BOLOGNA, DOMINIC JOSEPH | 2877 | §103 | Non-Final OA | 91d overdue | Pending | Oct 06, 2022 |
| 17917472 | NUCLEIC ACID CONSTRUCTS COMPRISING GENE EDITING MULTI-SITES | Io Biosciences, Inc. | ALLEN, SARAH ELIZABETH | 1637 | Other | Non-Final OA | 30d overdue | Pending | Oct 06, 2022 |
| 17937724 | COLOCALIZATION-BY-LINKAGE SANDWICH ASSAYS | Nomic Bio Inc. | GUSSOW, ANNE | 1683 | §103 | Non-Final OA | 59d overdue | Pending | Oct 03, 2022 |
| 17936089 | METHODS AND COMPOSITIONS FOR TREATING CANCER | Engine Biosciences Pte. Ltd. | VISHNYAKOVA, ELENA VLADIMIROVNA | 1691 | §103 | Non-Final OA | 28d overdue | Pending | Sep 28, 2022 |
| 17935690 | DEGRADER-ANTIBODY CONJUGATES AND METHODS OF USING SAME | Anglex, Inc. | CARTER, SANDRA DILLAHUNT | 1674 | §112 | Non-Final OA | 73d overdue | Pending | Sep 27, 2022 |
| 17953260 | METHODS OF ENHANCING NEUROSTIMULATION DURING ACTIVITIES | Cognito Therapeutics, Inc. | COX, THADDEUS B | 3791 | §103 | Non-Final OA | 84d overdue | Pending | Sep 26, 2022 |
| 17934945 | PHARMACOLOGY OF VISUAL CYCLE MODULATORS | Acucela Inc. | HUANG, GIGI GEORGIANA | 1613 | Other | Final Rejection | 55d | Pending | Sep 23, 2022 |
| 17906735 | CANNABINOID COMPOSITIONS | The Queen's Medical Center | GULLEDGE, BRIAN M | 1699 | Other | Non-Final OA | 98d overdue | Pending | Sep 19, 2022 |
| 17906183 | MULTIPLEXED COLOCALIZATION-BY-LINKAGE ASSAYS FOR THE DETECTION AND ANALYSIS OF ANALYTES | Nomic Bio Inc. | TRAN, CHAU NGUYEN BICH | 1677 | Other | Non-Final OA | 97d overdue | Pending | Sep 12, 2022 |
| 17930840 | STEM CELL STIMULATING COMPOSITIONS AND METHODS | Medicell Technologies, LLC | YU, HONG | 1614 | §103 | Non-Final OA | 32d overdue | Pending | Sep 09, 2022 |
| 17905911 | Engineered PlyAB Nanopores and Uses Thereof | Rijksuniversiteit Groningen | LEE, JAE W | 1656 | §102 | Non-Final OA | 33d | Pending | Sep 08, 2022 |
| 17901573 | SCALABLE BIOREACTOR SYSTEMS AND RELATED METHODS OF USE | Mission Barns, Inc. | HURST, JONATHAN M | 1799 | §103 | Non-Final OA | 14d | Pending | Sep 01, 2022 |
| 17896355 | METHODS AND SYSTEMS FOR DETERMINING ANCESTRAL RELATEDNESS | Embark Veterinary, Inc. | AUGER, NOAH ANDREW | 1687 | Other | Non-Final OA | 34d | Pending | Aug 26, 2022 |
| 17894884 | OPHTHALMIC COMPOSITION | Sydnexis, Inc. | LEE, WILLIAM Y | 1623 | Other | Final Rejection | 55d | Pending | Aug 24, 2022 |
| 17818951 | FORMULATIONS FOR ADMINISTRATION OF EFLORNITHINE | Orbus Therapeutics, Inc. | BRAUN, MADELINE E | 1624 | §103 | Final Rejection | 149d overdue | Pending | Aug 10, 2022 |
| 17798421 | METHODS OF KILLING OR INHIBITING THE GROWTH OF CANCER CELLS | BIOTISSUE HOLDINGS INC. | RICCI, CRAIG D | 1611 | §103 | Final Rejection | 98d overdue | Pending | Aug 09, 2022 |
| 17760298 | THERAPEUTIC COMBINATIONS COMPRISING A RAF INHIBITOR FOR USE IN TREATING BRAF MUTANT NSCLC | Novartis AG | ROBINSON, MIKHAIL O'DONNEL | 1627 | §103 | Final Rejection | 58d overdue | Pending | Aug 05, 2022 |
| 17882009 | MICRORNA COMPOSITIONS AND METHODS OF USE | New York R&D Center For Translational Medicine And Therapeutics, Inc. | VYAS, KEYUR ANILKUMAR | 1637 | §103 | Non-Final OA | 5d overdue | Pending | Aug 05, 2022 |
| 17880013 | ACOUSTIC OTOSCOPE | Otonexus Medical Technologies, Inc. | DOUGHERTY, SEAN PATRICK | 3791 | §103 | Final Rejection | 56d | Pending | Aug 03, 2022 |
| 17875719 | WEARABLE DEVICE AND METHOD FOR REMOTE OPTICAL MONITORING OF INTRAOCULAR PRESSURE | Smartlens, Inc. | TOTH, KAREN E | 3791 | §101 | Non-Final OA | 183d overdue | Pending | Jul 28, 2022 |
| 17871274 | LOW MOLECULAR WEIGHT PROTEIN COMPOSITIONS | Advance International Inc. | ZILBERING, ASSAF | 1792 | §103 | Non-Final OA | 52d overdue | Pending | Jul 22, 2022 |
| 17758656 | METHODS OF TARGETED SEQUENCING | Jumpcode Genomics, Inc. | GRAY, JESSICA | 1682 | §103 | Final Rejection | 72d overdue | Pending | Jul 12, 2022 |
| 17861176 | ANTIBODY CONJUGATES AND MANUFACTURE THEREOF | Bright Peak Therapeutics AG | BERHANE, SELAM | 1675 | §103 | Non-Final OA | 114d overdue | Pending | Jul 09, 2022 |
| 17790797 | METHODS AND COMPOSITIONS FOR PRODUCTION OF XENOGENEIC ISLET CELLS AND TREATMENT OF INSULIN-RESISTANT OR -DEFICIENT CONDITIONS WITH THE SAME | Hangzhou Qihan Biotechnology Co., Ltd. | NOBLE, MARCIA STEPHENS | 1632 | §112 | Final Rejection | 9d | Pending | Jul 05, 2022 |
| 17853436 | DEVICES AND METHODS FOR TREATING CANCER AND CARDIAC WASTING | Nazzano Devices Limited | GHAND, JENNIFER LEIGH-STEWAR | 3796 | §103 | Non-Final OA | 88d overdue | Pending | Jun 29, 2022 |
| 17848842 | SYSTEMS AND METHODS FOR CONTEXT-INDEPENDENT DATABASE SEARCH PATHS | Datawalk Spólka Akcyjna | HOANG, KEN | 2168 | §103 | Final Rejection | 10d overdue | Pending | Jun 24, 2022 |
| 17846288 | Compositions and Methods for Simultaneously Modulating Expression of Genes | Versameb AG | WHITEMAN, BRIAN A | 1636 | Other | Non-Final OA | 29d | Pending | Jun 22, 2022 |
| 17843896 | THYMIDINE KINASE GENE | Genvivo, Inc. | KELLY, ROBERT M | 1638 | §101 | Final Rejection | 161d overdue | Pending | Jun 17, 2022 |
| 17841029 | POLYNUCLEOTIDE EDITORS AND METHODS OF USING THE SAME | Prime Medicine, Inc. | MARVICH, MARIA | 1634 | §102 | Non-Final OA | 59d overdue | Pending | Jun 15, 2022 |
| 17841267 | COMBINATIONS OF FLAVIVIRUS PROTEINS, PEPTIDE SEQUENCES, EPITOPES, AND METHODS AND USES THEREOF | La Jolla Institute For Immunology | CHEN, STACY BROWN | 1672 | §103 | Non-Final OA | 154d overdue | Pending | Jun 15, 2022 |
| 17784841 | OPHTHALMIC COMPOSITIONS COMPRISING D2O | Sydnexis, Inc. | KENYON, JOHN S | 1625 | Other | Non-Final OA | 1d overdue | Pending | Jun 13, 2022 |
| 17837920 | Heparin-Associated Polypeptides and Uses Thereof | Juvena Therapeutics, Inc. | SAOUD, CHRISTINE J | 1645 | Other | Non-Final OA | 37d overdue | Pending | Jun 10, 2022 |
| 17782010 | CELL INJECTION PRINTING WITH A COAXIAL NEEDLE | Scripps Health | CARPENTER, WILLIAM R | 3783 | §103 | Non-Final OA | 42d overdue | Pending | Jun 02, 2022 |
| 17830073 | TREATING COGNITIVE DISORDERS USING TRAPIDIL | Sinopia Biosciences, Inc. | ADLAM, CHANTAL PETA-GAYE | 1622 | Other | Final Rejection | 104d overdue | Pending | Jun 01, 2022 |
| 17780227 | SYSTEMS AND DEVICES FOR SAMPLE PREPARATION AND ANALYTE DETECTION | Nucleix Ltd. | BRAZIN, JACQUELINE | 1798 | §103 | Non-Final OA | 55d | Pending | May 26, 2022 |
| 17824237 | SOLID DISPERSION OF PAN-RAF KINASE INHIBITOR | Day One Biopharmaceuticals, Inc. | JANOSKO, CHASITY PAIGE | 1613 | §103 | Non-Final OA | 74d overdue | Pending | May 25, 2022 |
| 17777788 | OPTICAL APPARATUS | Tympa Health Technologies Ltd. | COMSTOCK, DAVID C | 3773 | Other | Non-Final OA | 8d overdue | Pending | May 18, 2022 |
| 17777757 | Artificial nanopores and uses and methods relating thereto | Rijksuniversiteit Groningen | GERIDO, DWAN A | 1797 | §103 | Final Rejection | 23d | Pending | May 18, 2022 |
| 17746180 | DEVICES AND METHODS FOR DELIVERING BLOOD FROM A LOWER PRESSURE REGION TO A HIGHER PRESSURE REGION | Cardiost, Inc. | RAYMOND, LINNAE ELIZABETH | 3781 | §103 | Non-Final OA | 111d overdue | Pending | May 17, 2022 |
| 17776839 | IMMORTALIZED CARDIAC STEM CELLS FOR CARDIAC REPAIR | Secretome Therapeutics, Inc. | BARRON, SEAN C | 1653 | §103 | Final Rejection | 98d overdue | Pending | May 13, 2022 |
| 17739526 | GENE EXPRESSION SIGNATURE OF ENDOMETRIAL SAMPLES FROM WOMEN WITH AND WITHOUT ENDOMETRIOSIS | Endometrics Ltd. | CASH, KAILEY ELIZABETH | 1683 | §101 | Non-Final OA | 32d overdue | Pending | May 09, 2022 |
| 17735084 | Ionic Air Flow Generator, With Emitter And Collector Stripes | Ventiva, Inc. | OSENBAUGH-STEWART, ELIZA W | 2881 | §112 | Non-Final OA | 28d overdue | Pending | May 02, 2022 |
| 17772832 | METHODS FOR THE CHARACTERIZATION OF FLUID | NextGen Jane, Inc. | BICKHAM, DAWN MARIE | 1685 | §102 | Non-Final OA | 61d | Pending | Apr 28, 2022 |
| 17730745 | WIRED CONTINUOUS GLUCOSE MONITORING INFUSION SET | Pacific Diabetes Technologies Inc. | STANEK, KELSEY L | 3741 | §103 | Non-Final OA | 51d overdue | Pending | Apr 27, 2022 |
| 17771945 | IMPROVED METHODS, KITS, COMPOSITIONS AND DOSING REGIMENS FOR THE USE OF HETEROCYCLIC INHIBITORS OF ERK1 AND ERK2 | Asana Biosciences, LLC | HEITMEIER, KENDALL NICOLE | 1621 | Other | Final Rejection | 103d overdue | Pending | Apr 26, 2022 |
| 17770807 | SAMPLE PREPARATION AND SEQUENCING ANALYSIS FOR REPEAT EXPANSION DISORDERS AND SHORT READ DEFICIENT TARGETS | Jumpcode Genomics, Inc. | BUCHANAN, BAILEY CHEYENNE | 1682 | §103 | Final Rejection | 49d overdue | Pending | Apr 21, 2022 |
| 17770803 | DE-NOVO K-MER ASSOCIATIONS BETWEEN MOLECULAR STATES | Jumpcode Genomics, Inc. | VANN-OJUEKAIYE, KENDRA RAYCHELL | 1682 | §103 | Final Rejection | 5d overdue | Pending | Apr 21, 2022 |
| 17721838 | OPHTHALMIC COMPOSITION | Sydnexis, Inc. | TRAN, ERIC | 1629 | DPOther | Non-Final OA | 69d | Pending | Apr 15, 2022 |
| 17721831 | OPHTHALMIC COMPOSITION | Sydnexis, Inc. | TRAN, ERIC | 1629 | §103 | Non-Final OA | 8d overdue | Pending | Apr 15, 2022 |
| 17719042 | INHALABLE IMATINIB FORMULATION | Inaya Therapeutics, Inc. | LANDAU, SHARMILA GOLLAMUDI | 1653 | §103 | Final Rejection | 107d overdue | Pending | Apr 12, 2022 |
| 17715917 | METHODS AND SYSTEMS FOR NUCLEIC ACID EXTRACTION | Seek Labs, Inc. | BORTOLI, JONATHAN | 1797 | §103 | Non-Final OA | 20d | Pending | Apr 07, 2022 |
| 17715772 | INTERACTIVE MEDIA | Ta-Da! Language Productions, Inc. | POLLOCK, ZACHARY JOSEPH | 3715 | §103 | Final Rejection | 43d overdue | Pending | Apr 07, 2022 |
| 17761696 | COMPOSITIONS AND METHODS FOR TEMPLATE-FREE DOUBLE STRANDED GEOMETRIC ENZYMATIC NUCLEIC ACID SYNTHESIS | Derek Stemple | PARISI, JESSICA DANIELLE | 1684 | §103 | Final Rejection | 13d | Pending | Mar 18, 2022 |
| 17684628 | 3D DATA GENERATION FOR PROSTHETIC CROWN PREPARATION OF TOOTH | Cyberdontics (Usa), Inc. | LUCCHESI, NICHOLAS D | 3772 | §103 | Non-Final OA | 32d overdue | Pending | Mar 02, 2022 |
| 17683975 | METHODS FOR SEQUENCING NUCLEIC ACID MOLECULES | 13.8, Inc. | RILEY, JEZIA | 1681 | §103 | Non-Final OA | 89d overdue | Pending | Mar 01, 2022 |
| 17638760 | HEPARIN AND HEPARAN SULFATE FROM MODIFIED MAST CELLS AND METHODS OF MAKING AND USING | Tega Therapeutics, Inc. | SABILA, MERCY HELLEN | 1654 | Other | Final Rejection | 60d overdue | Pending | Feb 25, 2022 |
| 17681560 | OPHTHALMIC COMPOSITION | Sydnexis, Inc. | SIMMONS, CHRIS E | 1622 | Other | Final Rejection | 23d overdue | Pending | Feb 25, 2022 |
| 17637737 | COMPOSITIONS FOR MONOCYTE AND MACROPHAGE POLARIZATION AND METHODS OF USE | Orbsen Therapeutics Limited | ABBOTT, KODYE LEE | 1634 | §103 | Final Rejection | 6d | Pending | Feb 23, 2022 |
| 17635985 | POST-ABLATIVE MODULATION OF RADIATION THERAPY | Montefiore Medical Center | COX, THADDEUS B | 3791 | §102 | Non-Final OA | 35d | Pending | Feb 16, 2022 |
| 17635695 | SYSTEMS, DEVICES, AND METHODS FOR OBSERVING A COMPUTER NETWORK AND/OR SECURING DATA ACCESS TO A COMPUTER NETWORK | Arete Security Inc. Dba Druvstar | VU, TAYLOR P | 2437 | §103 | Non-Final OA | 36d overdue | Pending | Feb 15, 2022 |
| 17587643 | SYSTEMS AND METHODS FOR ASSESSING A TARGET MOLECULE | Axbio Inc. | LEE, JAE W | 1656 | §103 | Non-Final OA | 21d | Pending | Jan 28, 2022 |
| 17584892 | MULTISPECIFIC AND MULTIFUNCTIONAL MOLECULES AND USES THEREOF | Marengo Therapeutics, Inc. | CANELLA, KAREN A | 1643 | Other | Final Rejection | 16d | Pending | Jan 26, 2022 |
| 17630503 | SINGLE USE ENDOSCOPES, CANNULAS, AND OBTURATORS WITH INTEGRATED VISION AND ILLUMINATION | Noah Medical Corporation | SONG, LI-TING | 3795 | §103 | Final Rejection | 91d overdue | Pending | Jan 26, 2022 |
| 17581706 | PLATELET-FACILITATED DELIVERY OF THERAPEUTIC COMPOUNDS | Csts Health Care Inc. | CANELLA, KAREN A | 1643 | Other | Final Rejection | 11d overdue | Pending | Jan 21, 2022 |
| 17580419 | CELL TREATMENTS AND THERAPEUTIC REINFUSION METHODS | Cryommune, LLC | BEHARRY, ZANNA MARIA | 1632 | §103 | Final Rejection | 111d overdue | Pending | Jan 20, 2022 |
| 17578886 | MACHINE LEARNING METHODS TO OPTIMIZE CONCRETE APPLICATIONS AND FORMULATIONS | AlCrete Corp. | REYES, MARIELA D | 2142 | §103 | Final Rejection | 35d overdue | Pending | Jan 19, 2022 |
| 17558865 | Systems and Methods for Inferring Taxonomies in Manufacturing Processes | Oden Technologies Ltd. | ROBINSON, GRETA LEE | 2163 | §102 | Final Rejection | 11d overdue | Pending | Dec 22, 2021 |
| 17556068 | METHODS AND SYSTEMS FOR IDENTIFYING TARGET GENES | Algen Biotechnologies, Inc. | MINCHELLA, KAITLYN L | 1685 | Other | Final Rejection | 2d overdue | Pending | Dec 20, 2021 |
| 17554181 | SYSTEMS FOR SAMPLE ANALYSIS | Biomeme, Inc. | GIAMMONA, FRANCESCA FILIPPA | 1681 | Other | Non-Final OA | 3d overdue | Pending | Dec 17, 2021 |
| 17620427 | FORMULATIONS OF RBP4 INHIBITORS AND METHODS OF USE | BELITE BIO, LLC | KUCHARCZK, JED A | 1623 | §103 | Non-Final OA | 49d overdue | Pending | Dec 17, 2021 |
| 17616281 | COMPOSITIONS AND METHODS RELATING TO TUMOR ACTIVATED T CELL ENGAGERS | Janux Therapeutics, Inc. | LUNDE, GRACE HENRY | 1641 | Other | Non-Final OA | 127d overdue | Pending | Dec 03, 2021 |
| 17616244 | SYSTEMS AND METHODS FOR DETERMINING SEQUENCE | Xgenomes Corp. | ANDERSON-FEARS, KEENAN NEIL | 1687 | §103 | Non-Final OA | 77d overdue | Pending | Dec 03, 2021 |
| 17534000 | METHODS AND KITS FOR DETECTING PATHOGENS | Clear Labs, Inc. | LEVERETT, MARY CHANG | 1687 | §103 | Non-Final OA | 66d overdue | Pending | Nov 23, 2021 |
| 17532791 | TRANSCRIPTIONAL RELAY SYSTEM | Octant, Inc. | STAVROU, CONSTANTINA E | 1632 | §103 | Non-Final OA | 14d | Pending | Nov 22, 2021 |
| 17611838 | CELLS, TISSUES, ORGANS, AND/OR ANIMALS HAVING ONE OR MORE MODIFIED GENES FOR ENHANCED XENOGRAFT SURVIVAL AND/OR TOLERANCE | Hangzhou Qihan Biotechnology Co., Ltd. | BATES, KEENAN ALEXANDER | 1631 | Other | Final Rejection | 27d | Pending | Nov 16, 2021 |
| 17610899 | ACTIVATABLE BISPECIFIC ANTIBODIES COMPRISING A LINKER BETWEEN THE TWO BINDING DOMAINS WHICH IS A HUMAN IMMUNOGLOBULIN HINGE REGION, OR A VARIANT THEREOF, AND USES THEREOF | Centessa Pharmaceuticals (Uk) Limited | LUNDE, GRACE HENRY | 1641 | §112 | Final Rejection | 19d | Pending | Nov 12, 2021 |
| 17518016 | BIOMARKERS FOR DIAGNOSING ALZHEIMER'S DISEASE | Seer, Inc. | TRAN, CHAU NGUYEN BICH | 1677 | §103 | Final Rejection | 5d overdue | Pending | Nov 03, 2021 |
| 17497373 | TISSUE GRASPING DEVICES AND RELATED METHODS | Medfree, Inc. | PRONE, CHRISTOPHER D | 3774 | — | Non-Final OA | 169d overdue | Pending | Oct 08, 2021 |
| 17490160 | METHOD OF DETERMINING PERCENTAGE OF IMMUNE CELL TYPES IN A SALIVA SPECIMEN | Tru Diagnostics, Inc. | JOHANSEN, PETER N. | 1644 | §103 | Non-Final OA | 70d | Pending | Sep 30, 2021 |
| 17598052 | DIGITAL HEALTH ECOSYSTEM | Nucleix Ltd. | WALTERS, RYAN J | 3799 | §103 | Final Rejection | 28d overdue | Pending | Sep 24, 2021 |
| 17478571 | SYSTEMS, METHODS AND DEVICES FOR MONITORING, EVALUATING AND PRESENTING HEALTH RELATED INFORMATION, INCLUDING RECOMMENDATIONS | January, Inc. | HRANEK, KAREN AMANDA | 3684 | §103 | Final Rejection | 15d overdue | Pending | Sep 17, 2021 |
| 17406847 | MODIFIED IL-18 POLYPEPTIDES AND USES THEREOF | Bright Peak Therapeutics AG | FORD, VANESSA L | 1674 | §103 | Final Rejection | 73d overdue | Pending | Aug 19, 2021 |
| 17402365 | INTEGRATED SLEW DRIVES FOR ACTUATION OF TELECOMMUNICATION SYSTEMS AND OTHERS | Kinematics, LLC | RUSHING, JR, BOBBY | 3618 | §103 | Final Rejection | 28d overdue | Pending | Aug 13, 2021 |
| 17430102 | METHODS FOR TARGETED DEPLETION OF NUCLEIC ACIDS | Jumpcode Genomics, Inc. | RAYMONDA, MATTHEW HAROLD | 1684 | Other | Final Rejection | 38d overdue | Pending | Aug 11, 2021 |
| 17427192 | METHODS AND COMPOSITIONS FOR DEVELOPING TARGET SPECIFIC EXOSOME AND GROWTH FACTOR PRODUCTS | Direct Biologics, LLC | GOLDBERG, JEANINE ANNE | 1682 | §103 | Non-Final OA | 126d overdue | Pending | Jul 30, 2021 |
| 17378404 | NEURAL NETWORK ARCHITECTURES FOR LINKING BIOLOGICAL SEQUENCE VARIANTS BASED ON MOLECULAR PHENOTYPE, AND SYSTEMS AND METHODS THEREFOR | Deep Genomics Incorporated | BICKHAM, DAWN MARIE | 1685 | §101 | Final Rejection | 141d overdue | Pending | Jul 16, 2021 |
| 17369499 | SYSTEMS AND METHODS FOR CLASSIFYING, PRIORITIZING AND INTERPRETING GENETIC VARIANTS AND THERAPIES USING A DEEP NEURAL NETWORK | Deep Genomics Incorporated | ANDERSON-FEARS, KEENAN NEIL | 1687 | Other | Non-Final OA | 60d overdue | Pending | Jul 07, 2021 |
| 17348876 | RNA ENCODING A PROTEIN WITH A HETEROLOGOUS SIGNAL PEPTIDE | Versameb AG | SULLIVAN, STEPHANIE LAUREN | 1635 | §103 | Non-Final OA | 89d overdue | Pending | Jun 16, 2021 |
| 17296733 | Intact Pea Protein-Based Nutrient Composition | Kate Farms, Inc. | CAIN, JENNIFER LYNN | 1655 | §103 | Final Rejection | 44d overdue | Pending | May 25, 2021 |
| 17291580 | TWO-GENE VECTORS FOR GENERATING CAR-T CELLS AND USES THEREOF | Medisix Therapeutics, Inc. | AEDER, SEAN E | 1642 | §103 | Final Rejection | 80d overdue | Pending | May 05, 2021 |
| 17243452 | CELL-FREE RNA LIBRARY PREPARATIONS | Superfluid Dx, Inc. | TSAY, MARSHA M | 1656 | §103 | Final Rejection | 18d overdue | Pending | Apr 28, 2021 |
| 17222419 | COMPOSITIONS AND METHODS FOR POST-OPERATIVE OCULAR CARE | Ocular Science, Inc. | RODRIGUEZ, RAYNA B | 1628 | §103 | Final Rejection | 66d overdue | Pending | Apr 05, 2021 |
| 17196825 | METHOD AND SYSTEM FOR ESTIMATING PHYSICAL QUANTITIES OF A PLURALITY OF MODELS USING A SAMPLING DEVICE | 1QB Information Technologies Inc. | FIGUEROA, KEVIN W | 2124 | §101 | Final Rejection | 72d overdue | Pending | Mar 09, 2021 |
| 17167949 | MICROFLUIDIC DEVICES AND USES THEREOF | Signal Biosystems, Inc. | GORDON, BRIAN R | 1798 | §103 | Non-Final OA | 2d overdue | Pending | Feb 04, 2021 |
| 17107701 | METHODS AND SYSTEMS FOR SAMPLE COLLECTION | Thorne Healthcare, Inc. | MISHRA, DEEPA | 1657 | §103 | Final Rejection | 111d overdue | Pending | Nov 30, 2020 |
| 17059994 | LOW-PROFILE MULTI-AGENT INJECTION SYSTEM AND METHODS | Presage Biosciences, Inc. | VARGAS, ANNA ELIZABETH | 3783 | §103 | Final Rejection | 8d overdue | Pending | Nov 30, 2020 |
| 17055513 | CRYSTALLINE FORMS OF 1-(ACYLOXY)-ALKYL CARBAMATE DRUG CONJUGATES OF NAPROXEN AND PREGABALIN | Xgene Pharmaceutical Inc. | MOU, LIYUAN | 1628 | §103 | Final Rejection | 72d overdue | Pending | Nov 13, 2020 |
| 17068135 | SYSTEMS AND METHODS FOR COMPLEX BIOMOLECULE SAMPLING AND BIOMARKER DISCOVERY | Seer, Inc. | KRIANGCHAIVECH, KETTIP | 1686 | §101 | Final Rejection | 73d overdue | Pending | Oct 12, 2020 |
| 17046465 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | Design Therapeutics, Inc. | CHONG, KIMBERLY | 1636 | §112 | Non-Final OA | 43d overdue | Pending | Oct 09, 2020 |
| 16960543 | HETERODUPLEX NUCLEIC ACID MOLECULES AND USES THEREOF | Atrium Therapeutics, Inc. | HILL, KEVIN KAI | 1638 | Other | Non-Final OA | 21d | Pending | Jul 07, 2020 |
| 16908426 | OPHTHALMIC COMPOSITION | Sydnexis, Inc. | SHOWALTER, ALEXANDER KEITH | 1629 | §103 | Final Rejection | 93d overdue | Pending | Jun 22, 2020 |
| 16889530 | SYSTEMS AND METHODS FOR QUERYING DATABASES USING INTERACTIVE SEARCH PATHS | Datawalk Spólka Akcyjna | MARI VALCARCEL, FERNANDO MARIANO | 2159 | §103 | Non-Final OA | 110d overdue | Pending | Jun 01, 2020 |
| 16763933 | SYSTEMS, DEVICES, FORMULATIONS AND METHODS FOR CONTROLLED DRUG DELIVERY | BEXSON BIOMEDICAL, INC. | SCHMIDT, EMILY LOUISE | 3783 | §103 | Non-Final OA | 44d overdue | Pending | May 13, 2020 |
| 16760522 | CANCER DETECTION, CLASSIFICATION, PROGNOSTICATION, THERAPY PREDICTION AND THERAPY MONITORING USING METHYLOME ANALYSIS | Sinai Health System | SITTON, JEHANNE SOUAYA | 1682 | §103 | Final Rejection | 34d | Pending | Apr 30, 2020 |
| 16841487 | METHODS OF MANUFACTURING INJECTABLE MICROGEL SCAFFOLDS | Tempo Therapeutics, Inc. | HAGOPIAN, CASEY SHEA | 1617 | Other | Final Rejection | 18d overdue | Pending | Apr 06, 2020 |
| 16785411 | OPHTHALMIC COMPOSITION | Sydnexis, Inc. | SHOWALTER, ALEXANDER KEITH | 1629 | §103 | Final Rejection | 97d overdue | Pending | Feb 07, 2020 |
| 16718092 | NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF | Atrium Therapeutics, Inc. | CANELLA, KAREN A | 1643 | §103 | Non-Final OA | 118d overdue | Pending | Dec 17, 2019 |
| 16679109 | MACHINE LEARNING DISEASE PREDICTION AND TREATMENT PRIORITIZATION | Ampel Biosolutions, LLC | STRIEGEL, THEODORE CHARLES | 1685 | Other | Non-Final OA | 72d overdue | Pending | Nov 08, 2019 |
| 16499449 | SYSTEMS AND METHODS FOR PREDICTING AND MONITORING CANCER THERAPY | Predicine, Inc. | ZAHORIK, AMANDA MARY | 1636 | §103 | Non-Final OA | 70d overdue | Pending | Sep 30, 2019 |
| 16287023 | Directing Motion of Droplets Using Differential Wetting | Volta Labs, Inc. | KAUR, GURPREET | 1759 | §103 | Non-Final OA | 35d overdue | Pending | Feb 27, 2019 |
| 16153071 | METHOD FOR OPTIMIZING FLUORESCENCE-BASED DETECTION | Nomic Bio Inc. | DHARITHREESAN, NIDHI | 1686 | §103 | Final Rejection | 104d overdue | Pending | Oct 05, 2018 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial